Introduction {#s1}
============

The annotation of transcription units has traditionally heavily relied on the detection of RNA molecules. However, in the last decade, many genome-wide studies based on the direct detection of RNA polymerase II (RNAPII) have clearly established that transcription extends largely beyond the limits of regions annotated for coding functional RNA or protein products ([@bib28]; [@bib53]). The generalized presence of transcribing RNA polymerases, not necessarily associated to the production of stable RNAs, defines pervasive or hidden transcription, which is a conserved feature of both eukaryotic and prokaryotic transcriptomes.

In *S. cerevisiae*, pervasive transcription accounts for the production of a multitude of transcripts generally non-coding, many of which undergo degradation in the nucleus or the cytoplasm ([@bib28]; [@bib53]). Transcription termination limits the extension of many non-coding transcription events, compensating, to some extent, the promiscuity of initiation (for recent reviews see: [@bib29]; [@bib53]). In *Saccharomyces cerevisiae* cells, two main pathways are known for terminating normal and pervasive RNAPII transcription events ([@bib54]). The first is employed for termination of mRNA coding genes and depends on the CPF-CF (cleavage and polyadenylation factor-cleavage factor) complex. Besides participating in the production of mRNAs, this pathway is also important for transcription termination of several classes of non-coding RNAs, namely SUTs (stable unannotated transcripts) and XUTs (Xrn1-dependent unstable transcripts) ([@bib43]). Transcription terminated by this pathway produces RNAs that are exported to the cytoplasm and enter translation. If they contain premature stop codons, they are subject to the nonsense mediated decay and might not be detected in wild-type cells ([@bib74]; [@bib41]).

The second pathway depends on the NNS (Nrd1-Nab3-Sen1) complex and is responsible for terminating transcription of genes that do not code for proteins. Small nucleolar RNAs (snoRNAs) and cryptic unstable transcripts (CUTs), a prominent class of RNAPII pervasive transcripts, are typical targets of NNS-dependent termination. One important feature of this pathway is its association with proteins involved in nuclear RNA degradation such as the exosome and its cofactor, the Trf4-Mtr4-Air (TRAMP) complex. The released RNA is not exported to the cytoplasm but polyadenylated by TRAMP and nucleolytically attacked by the exosome that trims snoRNAs to their mature length and fully degrades CUTs.

Recent studies in yeast and other eukaryotes have shown that constitutive and regulated readthrough at terminators provides a very significant contribution to pervasive transcription ([@bib75]; [@bib23]; [@bib61]; [@bib9]). Fail-safe mechanisms are in place to back up termination and restrict transcription leakage at terminators. One of these mechanisms terminates 'stray' transcription by harnessing the capability of DNA-bound proteins to roadblock RNAPII. Roadblocked polymerases are then released from the DNA via their ubiquitination and likely degradation ([@bib12]).

The ubiquitous average coverage of the genome by transcription, coupled to the remarkable stability of the transcription elongation complex, raises the important question of the efficient coordination of machineries that must read, replicate, repair and maintain the same genomic sequences. The crosstalks between transcription and replication are paradigmatic in this respect.

Eukaryotic cells faithfully duplicate each of their chromosomes by initiating their replication from many origin sites ([@bib2]). To ensure once-and-only-once DNA replication per cell cycle, coordination of initiation from these different sites is guaranteed by a two-step mechanism: replication origins have to be licensed before getting activated ([@bib16]). Licensing occurs from late mitosis to the end of G1 and consists in the deposition of pre-RCs (pre-replication complexes) around origin sites. To do so, ORC (origin recognition complex) recognizes and binds specifically origin DNA where it recruits Cdc6 and Cdt1 to coordinate the deposition of the replicative helicase engine, the hexameric Mcm2-7 complex. At each licensed origin is deposited a pair of Mcm2-7 hexamers assembled head-to-head as a still inactive double-hexamer (DH) encircling DNA. At the G1/S transition and throughout S-phase, the orderly recruitment of firing factors onto the Mcm2-7 DH activates it, ultimately triggering the building of two replisomes synthesizing DNA from the origin ([@bib50]).

*S. cerevisiae* origins are specified in cis by the presence of Autonomously Replicating Sequences (ARSs). Within each ARS, ORC recognizes and binds specifically a bipartite DNA sequence composed of the ACS (ARS Consensus Sequence, 5'-WTTTATRTTTW-3'; [@bib49]; [@bib15]; [@bib3]) and the B1 element ([@bib57]; [@bib34]). The ACS oriented by its T-rich strand is generally found at the 5' ends of ARS sequences ([@bib19]). A-rich stretches are often present at the opposite end of ARSs and have been proposed to function as additional ACSs oriented opposite to the main ACS ([@bib8]; [@bib77]). Such secondary ACSs have been shown to strengthen pre-RC assembly at ARS *in vitro* and proposed to ensure ARS function *in vivo* by driving the cooperative recruitment of a second ORC ([@bib13]; see also [@bib76]). This contrasts with earlier *in vitro* reconstitutions of pre-RC assembly on single DNA molecules, supporting the recruitment of only one ORC per DNA ([@bib71]; [@bib18]). Whether one or two ORC molecules are recruited at ARSs *in vivo* for efficient pre-RC assembly is still not fully understood.

ACS presence is necessary but not sufficient for ARS function *in vivo*, as only a small fraction of all ACSs found in the *S. cerevisiae* genome corresponds to active ARSs ([@bib72]). Other DNA sequence elements and factors, including the structure of chromatin, participate to origin specification and usage. On the one hand, ORC binding at the ACS shapes NFR formation, nucleosome positioning and nucleosome occupancy, which all together maximize pre-RC formation ([@bib36]; [@bib19]; [@bib4]; [@bib59]). On the other hand, specific histone modifications mark replication initiation sites ([@bib73]) and chromatin-coupled activities ensure replication forks progression and origin efficiency ([@bib32]; [@bib14]; [@bib1]). The transcription machinery could participate to the establishment of a specific chromatin landscape and/or play a more direct role in the specification and function of origins. However, to what extent annotated and non-annotated transcription at and around origins can influence replication remains unclear.

The binding of general transcription factors such as Abf1 and Rap1, or even the tethering of transcription activation domains, TBP or Mediator components was shown to be required for efficient firing of a model ARS ([@bib42]; [@bib69]; see also [@bib31]). However, whether this implies the activation of transcription within origins has not been shown.

Strong transcription through ARSs has been demonstrated to be detrimental for their function ([@bib65]; [@bib70]; [@bib10]; [@bib44]; [@bib38]), and intragenic origins have been shown to be inactivated by meiotic-specific transcription ([@bib44]; [@bib7]). Inactivation of origins by transcription has been correlated to the impairment of ORC binding and pre-RC assembly, possibly because of steric conflicts with transcribing RNAPII ([@bib44]; [@bib38]). Strong transcription through origins was found to terminate, at least to some extent, within ARS sequences at cryptic termination sites, generating stable and polyadenylated transcripts ([@bib10]; [@bib40]). However, it was concluded that transcription termination within ARSs and origin function are not functionally linked, as mutationally impairing either one would not affect the other. In particular, it was found that transcription termination was not due to ORC roadblocking RNAPII and, conversely, that origin activity was not dependent on termination taking place within the ARS ([@bib10]; [@bib40]).

Even if unrestricted transcription inactivates intragenic origins ([@bib44]; [@bib7]), these cases hardly represent the chromosomal context of most mitotically active origins, which are intergenic ([@bib17]; [@bib39]; [@bib47]) and are generally not exposed to the levels of transcription found within genes. Most importantly, these earlier studies could not take into account the potential impact of annotated and non-annotated levels of pervasive transcription, which is not easily detected, due to the general instability of the RNA produced and to the poor resolution of many techniques for detecting RNAPII occupancy. Such generally low levels of transcription have been recently found to significantly impact the expression of canonical genes and to be limited by fail safe and redundant transcription termination pathways ([@bib9]; [@bib60]).

We investigated here the impact of physiological levels of pervasive transcription on the function of replication origins in *S. cerevisiae*. Using nucleotide-resolution transcription maps, we studied the transcriptional landscape around and within origins, regardless of annotations. Origins generate a characteristic footprint in the ubiquitous transcriptional landscape due to the pausing of RNAPII at origin borders. On the one hand, transcription terminates at the border of the primary ACS, in an ORC and pre-RC-dependent manner, by a mechanism that has roadblock features. On the other hand, RNAPII pauses upstream of the secondary ACS but terminates within the ARS. The low levels of pervasive transcription that enter ARSs negatively affect the efficiency of licensing and firing, with pervasive transcription incoming from the secondary ACS affecting origin function to a higher extent.

These results have important implications for understanding the impact of genomic location on origin specification, efficiency and timing of activation. Because pervasive transcription is conserved and generally increases with increased genome complexity, they are also susceptible to be relevant for the mechanism of replication initiation in other eukaryotes, particularly in metazoans.

Results {#s2}
=======

RNAPII pausing and transcription termination occur at ARS borders {#s2-1}
-----------------------------------------------------------------

Although considerable efforts have been made to annotate transcription units independently from the production of stable RNAs, many transcribed regions still remain imprecisely or poorly annotated in the *S. cerevisiae* genome. Addressing the potential impact of transcription on the function of replication origins therefore requires taking into account the actual physiological levels of transcription, regardless of annotation. For these reasons, we relied on high-resolution transcription maps derived from the direct detection of RNAPII by the sequencing of the nascent transcript (RNAPII PAR-CLIP, photo-activable ribonucleoside-enhanced UV-crosslink and immunoprecipitation) ([@bib63]). We also generated additional datasets using the analogous RNAPII CRAC, (crosslinking analysis of cDNAs, [@bib21]; [@bib9]). Both methods detect significant levels of transcription in many regions that lack annotations (data not shown; [@bib9]).

We retrieved a total of 228 origins that we oriented according to the direction of the T-rich strand of their proposed ACS ([@bib48]). Origins were then anchored at the 5\' ends of their ACS and the median distribution of RNAPII occupancy was plotted in a 1 kb window around the anchoring site ([Figure 1A](#fig1){ref-type="fig"}). Strikingly, RNAPII signal accumulates over the 200nt preceding the T-rich strand of the ACS and sharply decreases within the 25nt immediately preceding it ([Figure 1A](#fig1){ref-type="fig"}, blue trace; see also [Figure 1---figure supplement 2A--B](#fig1s2){ref-type="fig"} for the statistical significance of the signal loss over the primary ACSs). The RNAPII signal build-up suggests that pausing occurs before the ACS, while its abrupt reduction might indicate that transcription termination occurs immediately upstream of the site. This behavior is reminiscent of roadblock termination whereby transcription elongation is impeded by factors or complexes binding the DNA, and RNA polymerase is released following its ubiquitylation ([@bib12]; [@bib60]; [@bib9]). RNAPII signal also builds up from antisense transcription, although in a more articulated manner ([Figure 1A](#fig1){ref-type="fig"}, red trace) and starts declining on average 120nt upstream of the 5' border of the ACS.

![Metasite analysis of RNAPII occupancy and transcription termination at replication origins.\
(**A**) RNAPII PAR-CLIP metaprofile at replication origins. 228 confirmed ARSs were oriented according to the direction of the T-rich strand of their proposed ACSs (blue arrow) ([@bib48]) and aligned at the 5\' ends of the oriented ACSs (red dashed line). The median number of RNAPII reads ([@bib63]) calculated for each position is plotted. Transcription proceeding along the T-rich strand of the ACS is represented in blue and considered to be sense, while transcription on the opposite strand is plotted in red and considered to be antisense. (**B**). Distribution of poly(A)+RNA 3\'-ends at genomic regions surrounding replication origins. Origins were oriented and anchored as in **A**). 3\'-ends reads ([@bib60]) of RNAs extracted from wild-type cells (WT, blue) or cells in which both Rrp6 and Dis3 were depleted from the nucleus (*RRP6-DIS3-AA*, transparent red) were plotted. At each position around the anchor, the presence or absence of an RNA 3\'-end was scored independently of the read count. (**C**). Scheme of replication origins anchored at different ACS sequences. Left: sense polymerases transcribing upstream of primary ACSs (blue arrows) are colored in blue, while antisense polymerases transcribing upstream of secondary ACSs (orange arrows) are colored in red. Right: ARSs oriented according to antisense transcription were aligned at the 5\' ends of the primary ACSs (top, corresponds to red trace in **D**) or at the 5\' ends of the secondary ACSs (bottom, corresponds to black trace in **D**). (**D**). RNAPII PAR-CLIP metaprofile of antisense transcription aligned either to the 5' ends of the primary (red) or the secondary (black) ACSs, as shown in (**C**). As in (**A**), the median number of RNAPII reads calculated for each position is plotted. (**E**). Distributions of RNA 3'-ends and RNAPII at genomic regions aligned at secondary ACSs. Origins were oriented and aligned as in (**D**). At each position around the anchor, presence or absence of an RNA 3\'-end was scored independently of the read count (left y-axis). The distribution of RNAPII already shown in (**C**) is reported here for comparison (right y-axis).](elife-40802-fig1){#fig1}

Although the sharp decrease of RNAPII signal immediately preceding the ACS is suggestive of transcription termination, it is possible that RNAPII occupancy downstream of the ACS decreases because of a shorter persistency of the elongation complex in these regions, for instance because of higher transcription speed. We thus sought independent evidence of transcription termination before the ACS. Transcription termination is accompanied by release of the transcript and generally by its polyadenylation. Therefore, we mapped the distribution of polyadenylated RNA 3'-ends around origins as a proxy for transcription termination ([Figure 1B](#fig1){ref-type="fig"}, blue). Because roadblock termination produces RNAs that are mainly degraded in the nucleus, we also profiled the distribution of RNA 3'-ends in cells depleted for the two catalytic subunits of the exosome, Rrp6 and Dis3 ([@bib60]) ([Figure 1B](#fig1){ref-type="fig"}, transparent red). At each position around the ACS, we scored the number of genomic sites containing at least one RNA 3'-end without taking into consideration the read count at each site. This conservative strategy determines whether termination occurs at each position, and prevents high read count values from dominating the aggregate value. The distribution of RNA 3'-ends -- and therefore of transcription termination events -- closely mirrors the distribution of RNAPII on the T-rich strand of the ACS and peaks immediately upstream of the ACS. Note that because the whole read is taken into account to map RNAPII distribution, while only the terminal nucleotide is used to map the 3'-ends, the distribution of RNA 3'-ends is shifted downstream relative to the distribution of RNAPII. Importantly, and consistent with a roadblock mechanism, the 3'-end count upstream of the ACS is higher in the absence of the exosome ([Figure 1B](#fig1){ref-type="fig"}, transparent red), strongly suggesting that these termination events produce, at least to some extent, RNAs that are degraded in the nucleus. These peaks of RNA 3'-ends are significant, as demonstrated by the p-values associated to the frequencies of termination events observed around the ACS, which are significantly smaller than the ones detected in the flanking region (corrected p-value\<10^−20^, [Figure 1---figure supplement 2D](#fig1s2){ref-type="fig"} and Material and methods).

These observations strongly suggest that the landscape of pervasive transcription is significantly altered by the presence of replication origins. Incoming RNAPIIs are paused with an asymmetric pattern around ARSs and termination occurs upstream of the primary ACS.

To assess the origin of the asymmetry in RNAPII distribution, we considered the possibility that RNAPIIs transcribing in the antisense direction relative to the ACS might be paused at the level of putative secondary ACSs located downstream within the ARS. Such secondary ACSs, proposed to be positioned 70-400nt downstream and in the opposite orientation of the main ACS, have been shown to be required *in vitro* for efficient pre-RC assembly and suggested to play an important role for origin function *in vivo* ([@bib13]). The variable position of these secondary ACS sequences could explain why the antisense RNAPII meta-signal spreads over a larger region when ARSs are aligned to the 5\' ends of their primary ACSs ([Figure 1C](#fig1){ref-type="fig"}). We therefore mapped such putative secondary ACSs using a consensus matrix derived from the set of known primary ACSs ([@bib13]) (Table 2). As shown on [Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}, distances between the primary and the predicted secondary ACS distribute widely and preferentially cluster around ≈100nt (median 113.5), consistent with functional data obtained using artificial constructs ([@bib13]). As possibly expected, the calculated similarity scores for these predicted ACSs are generally lower than the ones calculated for the main ACSs (see the distribution in [Figure 1---figure supplement 1B](#fig1s1){ref-type="fig"}). When we aligned origins to the first position of their predicted secondary ACSs ([Figure 1C](#fig1){ref-type="fig"} and [Figure 1D](#fig1){ref-type="fig"}, black trace) we observed a significant sharpening of the RNAPII occupancy peak compared to the alignment on their primary ACSs ([Figure 1D](#fig1){ref-type="fig"}, compare red to black traces; [Figure 1C](#fig1){ref-type="fig"}; [Figure 1---figure supplement 2c](#fig1s2){ref-type="fig"} for the statistical significance of the signal loss over the secondary ACSs). This suggests that RNAPII is indeed pausing immediately upstream of the secondary ACS. Interestingly, when we aligned polyadenylated RNA 3\'-ends using the first position of the predicted secondary ACSs, we observed that transcription termination distributed preferentially ≈50nt after the anchor ([Figure 1E](#fig1){ref-type="fig"}, blue trace, compare to RNAPII distribution, black trace; see also [Figure 1---figure supplement 2E](#fig1s2){ref-type="fig"}) indicating that in most instances antisense transcription terminates downstream of the site of RNAPII pausing.

To better highlight the presence and the role of a roadblock (RB) at these origins, we examined local transcription by RNAPII CRAC under conditions in which an essential component of either the CPF-CF or the NNS termination pathways is affected, that is in an *rna15-2* mutant at the non-permissive temperature, or by depleting Nrd1 by the auxin-degron method ([@bib9]). We reasoned that defects in CPF-CF or the NNS pathways would affect the levels of neighboring readthrough transcription directed toward these origins and consequently increase the transcriptional loads challenging the roadblocks. Representative examples are shown in [Figure 2](#fig2){ref-type="fig"}.

![RNAPII occupancy at individual ARS detected by CRAC analysis.\
RNAPII occupancy at sites of roadblock detected upstream *ARS305* (**A**), *ARS413* (**B**), *ARS431* (**C**) and *ARS432.5* (or *ARS453*, (**D**) by CRAC ([@bib9]). The pervasive transcriptional landscape at these ARSs is observed in wild-type cells (WT, blue) or cells bearing a mutant allele for an essential component of the CPF-CF transcription termination pathway (*rna15-2*, green) at permissive (25°C, dark colors) or non-permissive temperature (37°C, light colors). In the case of *ARS305* (**A**), RNAPII occupancy is also shown in cells rapidly depleted for an essential component of the NNS transcription termination pathway through the use of an auxin-inducible degron tag (Nrd1-AID; (−) Auxin: no depletion, dark pink; (+) Auxin: depletion, light pink).](elife-40802-fig2){#fig2}

In the case of *ARS305* ([Figure 2A](#fig2){ref-type="fig"}), low levels of readthrough transcription are found at the terminators of the adjacent transcription units (*YCL049C* or CUT040) and are subjected to roadblock termination at both the main (blue) or the putative secondary ACSs (red, overlaps with the previously mapped B4 element ([@bib27])), respectively. Increase in readthrough transcription at the *YCL049C* gene in *rna15-2* cells (sense transcription, light green track) or at CUT040 upon Nrd1 depletion (antisense transcription, light pink track), leads to increased accumulation of RNAPII at both ACSs and to transcription invading the ARS.

Two ACSs were previously proposed for *ARS413* ([Figure 2B](#fig2){ref-type="fig"}): sense ACS1 ([@bib19]) and antisense ACS2 ([@bib48]). Transcription on the plus strand is strongly roadblocked at ACS1, while transcription on the minus strand is roadblocked at both ACS2 and ACS1. In both cases, transcription derives only from the upstream genes (*YDL073W* and *YDL072C*, respectively) because no additional initiation sites could be detected, even in cytoplasmic and nuclear RNA degradation mutants (data not shown). When the transcription load was increased by affecting the termination of *YDL073W* and *YDL072C* in *rna15-2* cells at the non-permissive temperature (light green tracks), RNAPII occupancy at the RBs increases and some readthrough within the ARS occurs. This example suggests that both ACSs are occupied by the ORC complex, although it is not clear whether they function in conjunction or alternatively in different cells.

Two additional examples are shown in [Figure 2](#fig2){ref-type="fig"}. In the case or *ARS431* ([Figure 2C](#fig2){ref-type="fig"}), the RB is more prominent on the site of the primary ACS and increases when the transcriptional load is higher due to readthrough from the upstream gene, *YDR297W,* in *rna15-2* cells. On the contrary, a prominent site of RB at the secondary ACS is observed at *ARS453* (or *ARS432.5*; [Figure 2D](#fig2){ref-type="fig"}), while the RB at primary ACS cannot be observed because transcription of CUT523 appears to terminate efficiently upstream.

Taken together, these results suggest that primary and secondary ACSs, both presumably bound by ORC, can induce RNAPII pausing at the borders of replication origins. However, while RNAPII generally pauses and terminates upstream of primary ACS sequences, RNAPII often pauses at secondary ACS but terminates downstream. Importantly, such ARS footprint in the pervasive transcription landscape ([Figure 2](#fig2){ref-type="fig"}) provides independent *in vivo* evidence of the role of secondary ACS sequences ([@bib13]), while our meta-analyses ([Figure 1](#fig1){ref-type="fig"}) strongly suggest a general functional difference between primary and secondary ACSs with regards to incoming transcription.

Termination of transcription at ARSs is mediated by ORC binding to the DNA {#s2-2}
--------------------------------------------------------------------------

Transcription termination around origins might depend on many termination factors. The main transcription termination pathways in *S. cerevisiae*, NNS- and CPF-dependent, rely on the recognition of termination signals on the nascent RNA. Release of the polymerase occurs therefore after the termination signals that have been transcribed and recognized. Transcription termination by roadblock, on the other hand, ensues from a collision of the transcription elongation complex with a DNA bound protein, and therefore occurs upstream of the termination signal. Another characteristic feature of roadblock termination is that the released RNA is subject to exosome-dependent degradation. Both features, termination upstream of the termination signal and nuclear degradation of the released transcripts, are compatible with the notion that roadblock termination occurs at origins. Still, it remains possible that termination at the immediate borders of origins depends on conserved external signals allowing the recruitment of CPF- or NNS- components. According to the position of RNAPII pausing, the most likely roadblocking factor would be the ORC complex bound to the ACS.

We therefore first verified that termination depends on the ACS sequence and to this end we cloned a 500 bp DNA fragment containing *ARS305* in a reporter system allowing the detection of transcription termination ([@bib52]) ([Figure 3](#fig3){ref-type="fig"}). This fragment conferred ACS-dependent mitotic maintenance to a centromeric version of the reporter construct, indicating that it is a functional ARS ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). In this system, a test terminator sequence is cloned between two promoters, the downstream of which allows the expression of a reporter gene, *CUP1*, which is required for yeast growth in the presence of copper ions ([Figure 3A](#fig3){ref-type="fig"}). Transcription from the upstream promoter interferes with and thus inactivates the promoter driving expression of *CUP1* unless the test sequence contains a terminator. Copper resistant is therefore a reliable, positive read out of the presence of a transcription terminator in the cloned sequence. Consistent with the notion that termination occurs at replication origins, insertion of *ARS305* in the orientation dictated by the T-rich strand of the ACS conferred robust copper-resistant growth to yeast cells ([Figure 3B](#fig3){ref-type="fig"}), Importantly, copper resistance was abolished when the ACS was mutated, strongly suggesting that termination is strictly dependent on the integrity of the ORC binding site.

![Analysis of transcription termination at *ARS305*.\
(**A**) Scheme of the reporter system ([@bib52]) used to assess termination at *ARS305. P~TETOFF~*: doxycycline-repressible promoter; *P~GAL~: GAL1* promoter. Termination of transcription at a candidate sequence (blue) allows growth on copper containing plates while readthrough transcription inhibits the *GAL1* promoter and leads to copper sensitivity, as indicated. (**B**) Growth assay of yeasts bearing reporters containing a Reb1-dependent terminator, ([@bib12], used as a positive control), or *ARS305* (lanes 1 and 3, respectively). Variants containing mutations in the Reb1 binding site (Reb1 BS '−\') or the ACS sequence are spotted for comparison (lanes 2 and 4, respectively). (**C**) Northern blot analysis of *P~TET~* transcripts produced in wild-type and *rrp6∆* cells from reporters containing either a Reb1-binding site (Reb1 BS, lanes 1--2) or wild-type or mutant *ARS305* sequences, as indicated (lanes 3--8). Transcripts terminated within *ARS305* or at the *CUP1* terminator are highlighted.](elife-40802-fig3){#fig3}

This notion was further supported by Northern blot analysis of the transcripts produced when a shorter *ARS305* fragment containing the ACS and the downstream 154nt were introduced in the same reporter construct ([Figure 3C](#fig3){ref-type="fig"}). A short transcript witnessing the occurrence of termination was readily detected in the presence of *ARS305* (lane 3). Consistent with the notion that roadblock termination occurs at *ARS305*, the transcript released was subject to exosomal degradation and was stabilized by deletion of Rrp6 (lane 4). This short RNA disappeared when the ACS sequence was mutated, to the profit of a longer species resulting from termination downstream of *ARS305*, confirming the ACS-dependency of termination (lane 5). *ARS305* contains, in addition to the ACS, two motifs, B1 and B4, required for full origin function ([@bib27]). Interestingly, B4 is located roughly 100nt downstream of the ACS, and coincides with a predicted secondary ACS required for efficient symmetrical loading of the pre-RC ([Figure 2](#fig2){ref-type="fig"} and Table 2) ([@bib13]). To assess whether the primary ACS is sufficient to induce transcription termination, we mutated both B1 and B4, alone or in combination, and assessed the level of termination by Northern blot. As shown in lanes 6 and 7, mutation of B4 had the strongest effect on termination, which was very similar to the effect observed when the main ACS was mutated. Mutation of B1 had a minor but significant effect. From these experiments, we conclude that the high-affinity ORC-binding site alone is necessary but not sufficient for inducing transcription termination at *ARS305*, and that the secondary ACS (B4) and the B1 motif are additionally required.

To provide independent evidence that ORC bound to the ARS triggers transcription termination by a roadblock mechanism, we took advantage of the finding that many sequences with a perfect match to the ACS consensus do not bind ORC. We used published coordinates of ACSs bound (ORC-ACSs) or not recognized (nr-ACSs) by the ORC complex in ORC-ChIP-seq experiments ([@bib19]), and mapped transcripts 3'-ends ([@bib60]) as a proxy for the occurrence of transcription termination ([Figure 4A and B](#fig4){ref-type="fig"}). As previously, we oriented each ARS according to the direction of the T-rich ORC-ACS or nr-ACS. As expected, the distribution of transcription termination events around the set of ORC-bound ACSs is very similar to the one observed around replication origins mapped by [@bib48] (compare [Figure 4A](#fig4){ref-type="fig"} and [Figure 1B](#fig1){ref-type="fig"}). As in the previous analysis, many unstable transcripts are produced by termination around origins as witnessed by the overall higher level of 3\'-ends mapped in an exosome-deficient strain ([Figure 4A](#fig4){ref-type="fig"}). The distribution of RNA 3'-ends around the set of nr-ACSs is however radically different, with transcription events presumably crossing the nr-ACS in both directions and terminating downstream ([Figure 4B](#fig4){ref-type="fig"}). Interestingly, at nr-ACSs, the amounts of 3'-ends detected are very similar in wild-type conditions or upon depletion of both Rrp6 and Dis3 subunits of the nuclear exosome, indicating that termination downstream of nr-ACSs does not produce unstable transcripts and is presumably dependent on the CPF pathway ([Figure 4B](#fig4){ref-type="fig"}).

![Role of ORC in the roadblock of RNAPII at origins.\
(**A**) Distribution of RNA 3\'-ends at genomic regions aligned at ACS sequences recognized by ORC (ORC-ACS) as defined by [@bib19] (i.e. defined based on the best match to the consensus associated to each ORC-ChIP peak). Each origin was oriented according to the direction of the T-rich strand of its ORC-ACS and regions were aligned at the 5' ends of the ORC-ACSs. As in 1B, RNA 3\'-ends ([@bib60]) were from transcripts expressed in wild-type cells (blue) or from cells depleted for exosome components (transparent red). At each position around the anchor, presence or absence of an RNA 3\'-end was scored independently of the read count. Distributions of RNA 3'-ends both on the sense (top) and the antisense (bottom) strands relative to the ORC-ACSs are plotted. (**B**). Same as in (**A**) except that genomic regions were aligned at ACS sequences not recognized by ORC (nr-ACS) as defined by [@bib19] (i.e. defined as ACS motifs for which no ORC ChIP signal could be detected). (**C**). Quantification of the roadblock at individual ARSs. For each ARS, the snapshot includes the upstream gene representing the incoming transcription. The distribution of RNA polymerase II (dark blue) detected by CRAC ([@bib9]) at *ARS404* (left) and *ARS1004* (right) oriented according to the direction of their T-rich ACS strands is shown. The positions of the qPCR amplicons used for the RT-qPCR analyses in (**D**) are indicated. (**D**). RT-qPCR analysis of transcriptional readthrough at *ARS404* and *ARS1004*. Wild-type, *orc2-1*, *orc5-1* and *cdc6-1* cells were cultured at permissive temperature and maintained at permissive (23°C, blue) or non-permissive (37°C, red) temperature for 3 hr. The level of readthrough transcription at *ARS404* (left) or *ARS1004* ACS (right) was estimated by the ratio of RT-qPCR signals after and before the ACS, as indicated. Data were corrected by measuring the efficiency of qPCR for each couple of primers in each reaction. Values represent the average of at least three independent experiments. Error bars represent standard deviation.](elife-40802-fig4){#fig4}

Because the ACS sequence is nearly identical in the two datasets, it is unlikely that it alone could be responsible for the termination pattern observed at ORC-ACSs. These observations are consistent with the notion that the presence of ORC bound to the ACS is necessary to roadblock transcribing RNAPII, which releases a fraction of unstable RNAs. To substantiate these findings we set up to assess directly the impact of ORC depletion on transcribing RNAPII at two model origins, *ARS404* and *ARS1004*, located downstream of the *YDL227C* and *YJL217W* genes, respectively. In both cases, RNAPII signals are present immediately upstream of the T-rich strand of the ACS, presumably because of transcription events reading through the upstream terminator that are roadblocked at the site of ORC binding ([Figure 4C](#fig4){ref-type="fig"}). To assess the efficiency of the roadblock we measured RNA levels immediately upstream and downstream of the T-rich strand of each ACS in a strand-specific manner by RT-quantitative PCR ([Figure 4C and D](#fig4){ref-type="fig"}). Because no transcription initiation can be detected at either one of the two ACSs (data not shown), RNA signals detected downstream of the ACS are most likely due to molecules that initiate upstream and cross the ACS. We therefore expressed the efficiency of the roadblock as the ratio between the signals downstream and upstream of the ACS. Release of the roadblock is expected to increase this ratio because more RNAPII molecule would traverse the ACS. To affect binding of ORC to the ACS, we used two thermosensitive mutants of two ORC subunits, Orc2-1 and Orc5-1, which affect the binding of ORC to the DNA ([@bib62]; [@bib37]; [@bib78]; [@bib64]). As shown in [Figure 4D](#fig4){ref-type="fig"}, ORC roadblock at *ARS404* and *ARS1004* is efficient, allowing only between 1--10% of the incoming transcription to cross the ACS in wild-type cells or under permissive temperature for all mutants ([Figure 4D](#fig4){ref-type="fig"}, 23°C). When the binding of ORC to the ACS was affected in *orc2-1* and *orc5-1* cells at 37°C, a marked increase in the fraction of RNAPII going through the roadblock is observed, indicating that binding of the ORC complex to the ACS is necessary to terminate upstream incoming transcription.

Cdc6 binds DNA cooperatively with ORC and contributes to origin specification by participating to pre-RC assembly ([@bib67]; [@bib68]; [@bib78]) and references therein). The thermosensitive mutant Cdc6-1 ([@bib24]) which is affected in pre-RC assembly at the restrictive temperature ([@bib11]), still does not preclude ORC to footprint at candidate ARSs ([@bib62]). Remarkably, the transcriptional roadblock was markedly reduced in a *cdc6-1* mutant at the non-permissive temperature, to a similar extent as for the *orc2-1* and *orc5-1* mutants. This indicates that the assembly of an ORC•Cdc6 complex, or the full complement of the pre-RC at the candidate ARS, is essential for efficiently roadblocking RNAPII.

From these results, we conclude that the stable binding of the ORC complex to the ACS is necessary but not sufficient to efficiently terminate incoming transcription at ARS by a roadblock mechanism.

Impact of local pervasive transcription on ARS function {#s2-3}
-------------------------------------------------------

In spite of the presence of bordering roadblocks, low levels of pervasive transcription, which presumably originates in neighboring regions and cross the sites of ORC occupancy, were detected within replication origins ([Figures 1](#fig1){ref-type="fig"}--[3](#fig3){ref-type="fig"}). To assess the impact of local physiological levels of transcription within ARS, we sought correlations between total RNAPII occupancy on both ARS strands in a window of 100nt starting at the first base of the primary ACS, and licensing efficiency or origin activation ([@bib25]) We ordered the origins described by [@bib48] according to the levels of transcription at and immediately downstream of the T-rich ACS and compared the licensing efficiency of the 30 origins having the highest transcription levels to the rest of the population (160 origins) for which replication metrics were available (total of 190 origins) ([Supplementary file 1](#supp1){ref-type="supplementary-material"} Table 1). We found that the efficiency of licensing was significantly lower for the origins having the highest levels of transcription ([Figure 5A](#fig5){ref-type="fig"}; p = 0.003). We also found that origins having the highest levels of transcription display a lower probability of firing compared to the rest of the population ([Figure 5B](#fig5){ref-type="fig"}; p = 0.012).

![Local pervasive transcription impacts origin competence and efficiency.\
Transcription levels were assessed in the first 100 nt of each ARS, starting at the 5' end of the ACS, by adding RNAPII read counts ([@bib63]) on both strands of the region. Origins were ranked based on transcription levels and the origins having the highest transcription levels (30/192, grey boxplots) were compared to the rest of the population (162/192, white boxplots). Origin metrics (licensing, 5A, and firing efficiency, 5B) for the two classes of origins were retrieved from [@bib25]. Boxplots were generated with BoxPlotR (<http://shiny.chemgrid.org/boxplotr/>); center lines show the medians; box limits indicate the 25th and 75th percentiles; whiskers extend 1.5 times the interquartile range (IQR) from the 25th and 75th percentiles. Notches are 1.58\*IQR/n^1/2^.](elife-40802-fig5){#fig5}

The effect observed on origin firing might be a consequence of the impact of transcription on licensing. However, it is also possible that local levels of pervasive transcription impact origin activation after licensing. To address this possibility, we focused on the 30 origins that have the highest levels of incoming transcription as defined by the levels of RNAPII occupancy preceding ([Figure 6A](#fig6){ref-type="fig"}; 'A') and following ([Figure 6A](#fig6){ref-type="fig"}; 'C') a 200nt window aligned at the 5\' end of the ACS ([Figure 6A](#fig6){ref-type="fig"}; 'B') ([Supplementary file 1](#supp1){ref-type="supplementary-material"} Table 2, [Supplementary file 1](#supp1){ref-type="supplementary-material"} Table 3). Consistent with the previous analyses performed on all origins, transcription over 'B' strongly anticorrelated with origin competence (p = 2\*10^−4^; [Figure 6B](#fig6){ref-type="fig"}) and efficiency (p = 5\*10^−5^; [Figure 6C](#fig6){ref-type="fig"}). When we plotted the probability of licensing (P~L~) against the probability of firing (P~F~), we identified two classes of origins: the first that aligns almost perfectly on the diagonal (R^2^ = 0.99; [Figure 6D](#fig6){ref-type="fig"}, red) contains origins that fire with high probability once licensed. The second contains on the contrary origins firing with a lower probability, even when efficiently licensed ([Figure 6D](#fig6){ref-type="fig"}, black). As the probability of firing (P~F~) is the product of the probability of licensing (P~L~) by the probability of firing once licensing has occurred (P~F\|L~), the latter is defined by the ratio P~F~/P~L~. We then sought correlations between the total level of transcription over each ARS and the efficiency with which it is activated at the post-licensing step (P~F\|L~). Strikingly, origins that have a high P~F\|L~ are generally insensitive to transcription ([Figure 6E](#fig6){ref-type="fig"}, red); on the contrary, origins that have a low P~F\|L~ are markedly sensitive to the levels of overlapping transcription (R^2^ = 0.55; p = 0.002; [Figure 6E](#fig6){ref-type="fig"}, black). This generally holds true when the median time of firing ([@bib25]) is considered: origins with a high P~F\|L~ are generally firing earlier and in a manner that is independent from transcription levels over B ([Figure 6F](#fig6){ref-type="fig"}, red), while, conversely, origins that have a low P~F\|L~ tends to fire later when transcription over B increases (R^2^ = 0.44; p = 0.009; [Figure 6F](#fig6){ref-type="fig"}, black).

![Correlations between transcription and origin function.\
(**A**) Origins were first selected based on the levels of pervasive transcription to which they are exposed, calculated by adding RNAPII reads ([@bib63]) over the 'A' (sense direction) or the 'C' (antisense direction) regions. For the selected ARSs, levels of pervasive transcription were then calculated over the 'B' region by summing RNAPII reads over the 'B~a~' (sense direction) and the 'B~as~' (antisense direction) regions, as indicated in the scheme. (**B**) Correlation between transcription over the ARS and origin competence. (**C**) Correlation between transcription over the ARS and origin efficiency. (**D**) Identification of two classes of origins, one that fires with high probability when licensing has occurred (high P~F\|L~, red dots) and the other that fires less efficiently once licensed (low P~F\|L~, black dots). (**E**) Correlation between P~F\|L~ and transcription. The efficiency of firing at the post-licensing step correlates with the levels of pervasive transcription only for origins with low P~F\|L~ (black dots). Origins that fire very efficiently once licensing occurred (P~F\|L~≈1) are generally not sensitive to pervasive transcription (red dots). (**F**) Origins with a low P~F\|L~ (black dots) have a firing time that correlates with pervasive transcription, while origins with high P~F\|L~ (red dots) fire early independently of pervasive transcription levels.](elife-40802-fig6){#fig6}

We conclude that the efficiency of origin licensing generally negatively correlates with the levels of pervasive transcription within the ARS. Interestingly, a class of origins exists for which the local levels of transcription also impact origin activation after licensing.

Asymmetry of origin sensitivity to transcription {#s2-4}
------------------------------------------------

It has been suggested that the ORC complex binds the secondary ACS with lower affinity relative to the primary ACS ([@bib13]). If the affinity of ORC binding to DNA reflected its efficiency at roadblocking RNA polymerases, the existence of both primary and secondary ACSs might imply that incoming transcription upstream of the primary ACS (defined as 'sense' transcription) might be roadblocked more efficiently than incoming transcription upstream of the secondary ACS (defined as 'antisense' transcription). As a consequence, antisense transcription would be more susceptible to affect origin function. To assess the functional impact of this asymmetry, we turned to a natural model case, *ARS1206*, which immediately follows *HSP104*, a gene activated during heat shock ([Figure 7A](#fig7){ref-type="fig"}).

![Asymmetry of origin sensitivity to pervasive transcription.\
(**A**) Top: pervasive transcriptional landscape detected by RNAPII CRAC ([@bib9]) at *YLL026W* (*HSP104*) and *ARS1206* in wild-type cells, both on Watson (blue) and Crick (red) strands, at 25°C (dark colors) and 37°C (light colors). The 5\' ends and the sequences of the proposed primary ACS and the predicted secondary ACS for *ARS1206* are shown. Bottom: schemes of the reporters containing the *HSP104* gene and *ARS1206* placed under the control of a doxycycline-repressible promoter (*P~TETOFF~*). The position of the amplicon used for the qPCR in (**B**) is shown. pS and pAS differ for the orientation of *ARS1206*, with the primary (pS) or the secondary ACS (pAS) exposed to constitutive readthrough transcription from *HSP104*. The sequence and the organization of the relevant region are indicated on the right for each plasmid. The positions of the oligonucleotides used for RNaseH cleavage (black arrows) and of the probe used in (**C**) are also indicated. The sequences of the oligonucleotides is reported in Table 1, with the following correspondence: cleaving oligo 'a'=DL163; Northern probe = DL164; cleaving oligo 'b' = DL473; cleaving oligo 'c' = DL3991; cleaving oligo 'd' = DL3994. (**B**). Quantification by RT-qPCR of the *HSP104* mRNA levels expressed from pS or pAS in the presence or absence of 5 µg/mL doxycycline. The position of the qPCR amplicon is reported in (**A**). (**C**). Northern blot analysis of *HSP104* transcripts extracted from wild-type cells and subjected to RNAse H treatment before electrophoresis using oligonucleotides 'a-d' (positions shown in **A**). All RNAs were cleaved with oligonucleotide 'a' to decrease the size of the fragments analyzed and detect small differences in size. Cleavage with oligonucleotide 'b' (oligo-dT) (lanes 3, 4) allowed erasing length heterogeneity due to poly(A) tails. Oligonucleotides 'c' and 'd' were added in reactions run in lanes 1 and 6, respectively, to detect possible longer products that might originate from significant levels of transcription readthrough from *HSP104*, if the inversion of *ARS1206* were to alter the transcription termination efficiency. Products of RNAse H degradation were run on a denaturing agarose gel and analyzed by Northern blot using a radiolabeled *HSP104* probe (position shown in **A**). (**D**). Stability of plasmids depending on *ARS1206* for replication as a function of ARS orientation. pS or pAS was transformed in wild-type cells and single transformants were grown and maintained in logarythmic phase in YPD for several generations. To assess the loss of the transformed plasmid, cells were retrieved at the indicated number of generations and serial dilutions spotted on YPD (left) or minimal media lacking uracile (right) for 2 or 3 days, respectively, at 30°C. (**E**). Mutation of *ORC2* affects more severely the stability of pAS compared to pS. Transformation of pS and pAS in wild-type (*ORC2*, '−') or mutant (*orc2-1*, '+\') cells. Pictures were taken after 5 days of incubation at permissive temperature (23°C).](elife-40802-fig7){#fig7}

We cloned the *HSP104* coding sequence and the following *ARS1206* under the control of a doxycyclin*-*repressible promoter (P~TETOFF~), similar in strength and characteristics to the *HSP104* promoter ([@bib45]) ([Figure 7A](#fig7){ref-type="fig"}). We verified that the HSP104 gene is transcribed and produces a transcript similar in size to the endogenous *HSP104* RNA (data not shown), implicating that transcription termination occurs efficiently in this construct. This is expected to allow origin function, even under conditions of the strong transcription levels induced by the TET promoter. Indeed, after deletion of the ARS present in the plasmid backbone (*ARS1)*, the plasmid could still be maintained in yeast cells, showing that it can rely on *ARS1206* for replication (data not shown; [Figure 7D](#fig7){ref-type="fig"}).

We recently showed that transcription readthrough at canonical terminators is widespread in yeast and is one important component of pervasive transcription ([@bib9]). Although *ARS1206* is active, we predicted that the low levels of transcription reading through the *HSP104* terminator might impact its efficiency in an orientation-dependent manner. To test this hypothesis, we inverted the orientation of *ARS1206* on the plasmid, so that transcription from *HSP104* would approach the origin from its secondary ACS side ([Figure 7A](#fig7){ref-type="fig"}). We observed equivalent levels of *HSP104* expression from plasmids containing *ARS1206* in the sense (pS) or the antisense (pAS) orientation ([Figure 7B](#fig7){ref-type="fig"}) and concluded that transcription termination, which would have created unstable RNAs when impaired ([@bib35]), occured still efficiently upon *ARS1206* inversion. Consistently, high resolution Northern blot analysis of the 3'-ends of the *HSP104* RNA produced by pS and pAS confirmed that the site of polyadenylation was not altered by inversion of *ARS1206* and no readthrough RNAs could be detected ([Figure 7C](#fig7){ref-type="fig"}). Strikingly, when pS or pAS were transformed into wild-type cells, and yeasts were grown in a medium non-selective for plasmid maintenance for the same number of generations, *ARS1206* supported plasmid maintenance more efficiently when present on the sense (pS) relative to the antisense (pAS) orientation ([Figure 7D](#fig7){ref-type="fig"}).

This result is consistent with the notion that constitutive readthrough transcription from the *HSP104* gene affects origin function more markedly when approaching *ARS1206* from the side of the secondary ACS. This result is also consistent with the notion that incoming transcription is roadblocked more efficiently by ORC binding to the primary ACS as opposed to the secondary ACS, in line with the expected lower affinity of the latter interaction. To consolidate this result, we took advantage of previous work demonstrating that the *orc2-1* mutation has a stronger impact on the binding of ORC to ACSs having a poor match to the consensus, even at permissive temperature ([@bib26]). If binding of ORC to the ACS is the limiting factor for the functional asymmetry we observe, then affecting binding of ORC to the secondary, lower affinity site by the *orc2-1* mutation should exacerbate the instability of the pAS plasmid. Indeed, while pS could be as efficiently maintained in wild-type and *orc2-1* cells, pAS raised only sick uracil auxotroph transformants in the *orc2-1* background, indicating that it could not be efficiently propagated ([Figure 7E](#fig7){ref-type="fig"}).

We conclude that, while presence of primary and secondary ACSs at origin borders participates to the shielding of origins from pervasive transcription, this protection occurs asymmetrically.

Discussion {#s3}
==========

Transcription by RNA polymerase II occurs largely beyond annotated regions and produces a wealth of non-coding RNAs. Such non-coding transcription events have the potential to alter the chromatin landscape and affect in many ways the dynamics of other chromatin-associated processes. They originate from non-canonical transcription start site usage or from transcription termination leakage, as recently shown in the yeast and mammalian systems ([@bib75]; [@bib23]; [@bib61]; [@bib9]). Although the frequency of these events is generally low, the persistence of RNA polymerases is dependent on the speed of elongation and the occurrence of pausing and termination, potentially leading to significant occupancy at specific genomic locations where they could have a function. The crosstalks between transcription and replication have been traditionally analyzed in the context of strong levels of transcription, which, aside from a few specific cases, do not represent the natural exclusion of replication origins from regions of robust and generally constitutive transcription ([@bib39]; [@bib47]; [@bib17]). We studied here the impact of pervasive transcription on the specification and the function of replication origins. We demonstrate that origins have asymmetric properties in terms of the resistance to incoming transcription. The inherent protection of replication origins by transcription roadblocks limits the extent of transcription events within these regions. Nevertheless, polymerases that cross the roadblock borders impact both the efficiency of licensing and origin firing, demonstrating that physiological levels of pervasive transcription can shape the replication program of the cell. Importantly, since the global transcriptional landscape is sensitive to changes dictated by different physiological or stress conditions, pervasive transcription is susceptible to regulate the replication program according to cellular needs.

Replication initiates in regions of active transcription {#s3-1}
--------------------------------------------------------

Based on the presence and relative orientation of stable annotated transcripts, early studies have concluded that replication origins are excluded from regions of active transcription ([@bib17]; [@bib47]). To the light of our results it is clear that this notion needs to be revisited: if origins are generally excluded from regions of *genic* transcription, they dwell in a transcriptionally active environment populated by RNA polymerases that generate pervasive transcription events. These events have multiple origins and are generally of lower intensity relative to *bona fide* genic transcription. When ARSs are located in between divergent genes or more generally upstream of a gene, they might be exposed to natural levels of divergent transcription due to the intrinsic bidirectionality of promoters. When they are located downstream of a gene, they are potentially exposed to transcription naturally reading through termination signals ([@bib9]), which, depending on the level of expression of the gene and the robustness of termination signals, can be consequential.

Transcription termination occurs around and within origins {#s3-2}
----------------------------------------------------------

Nonetheless, origins are not porous to surrounding transcription and the presence of one ARS generates a characteristic footprint in the local RNAPII occupancy signal. When origins are oriented according to the main ORC binding site, the ACS, RNAPII signal is found to accumulate to some extent, depending on the levels of incoming transcription ([Figures 1A](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}), and sharply decrease in correspondence of the ACS. We provide several lines of evidence supporting the notion that RNAPII is paused at the site of ORC binding and that transcription termination occurs by a roadblock mechanism. First, we observed a relative enrichment of RNA 3\'-ends coinciding with the descending RNAPII signal, indicating that termination occurs at or before transcription has proceeded through the termination signal (the ACS). Second, a fraction of the RNAs produced are sensitive to exosomal degradation ([@bib12]; [@bib9]). Third, mutation of the ORC-binding site prevents efficient termination in our reporter system. Finally, mutational inactivation of ORC and Cdc6 erases the roadblock and allows transcription to cross the ACS at two natural model origins.

These findings are seemingly in contrast with earlier reports showing that inserting model ARSs in a context of strong transcription leads to transcription termination *within* ARSs independently of the ORC-binding site or other sequence signals required for origin function in replication ([@bib10]; [@bib40]). One possibility is that the cloned fragments in these early studies accidentally contain transcription termination signals, some of which were not annotated when these experiments were performed. This is likely the case for *ARS305* and *ARS209* that both contain a CUT directed antisense to the T-rich strand-oriented ACS. *ARS416* (ARS1) and *ARS209*, also used in these studies, might also contain termination signals from the contiguous *TRP1* and *HHF1* genes, respectively. Another possibility is that transcription termination occurred both at the roadblock site (the ACS) and internally, but the former was missed because of the poor stability of the RNA produced. As discussed below, we also found evidence of internal termination, but preferentially when examining the fate of antisense transcription (i.e. entering the ARS from the opposite side of the main ACS oriented by its T-rich strand).

The transcriptional footprint observed for antisense transcription shows a large peak when origins are aligned on the main ACS but condenses into a well-defined peak when the alignment is done on the presumed secondary ORC-binding sites ([@bib13]) ([Figure 1D](#fig1){ref-type="fig"}), suggesting that RNAPII indeed pauses at these sites. However, transcription termination, inferred from the distribution of RNA 3\'-ends, occurs downstream of the putative secondary ACS, within the ARS body ([Figure 1E](#fig1){ref-type="fig"}). Because these RNAs are stable, we suggest that they are generated by CPF-dependent termination, possibly because RNAPII encounters cryptic termination signals, or because the ARS chromatin environment prompts termination. Whether the occurrence of internal termination has functional implications for origin function is unclear; nevertheless, our analyses suggest that the presence of antisense RNAPIIs within the origin is important for modulating its function (see below).

Topological organization of replication origin factors detected by transcriptional footprinting {#s3-3}
-----------------------------------------------------------------------------------------------

We propose that the asymmetrical distribution of RNAPII at ARS borders relates to the 'quasi-symmetrical' model for pre-RC assembly on chromatin, as proposed by Coster and Diffley ([@bib13]). Earlier data suggested that binding of a single ORC molecule at a primary ACS is necessary and sufficient to drive the deposition of one Mcm2-7 double-hexamer (DH) around one DNA molecule ([@bib71]). However, given the topology of ORC binding to DNA ([@bib33]; [@bib34]) and the mode of Mcm2-7 deposition around DNA ([@bib20]), a drastic conformational change would be required to assemble one Mcm2-7 DH with only one ORC ([@bib79]; [@bib6]). The quasi-symmetrical model, in contrast, postulates that two distinct ORC molecules bind cooperatively each ARS at two distinct ACS sequences. One ORC binds the 'primary' ACS to load one half of the pre-RC, while the second ORC binds a 'secondary', degenerate ACS, to load the other half of the pre-RC in opposite orientation ([@bib77]; [@bib13]). Each Mcm2-7 hexamer translocating towards the other would then form the Mcm2-7 DH.

The transcriptional footprinting profile around origins shows an antisense RNAPII signal peaking at aligned potential secondary ACSs identified by their match to the consensus ([@bib13]), which testifies to the general functional significance of secondary ACSs prediction. The distribution of distances between the two 5\' ends of the two ACSs has a mode of 110nt, which is consistent with the expected physical occupancy of at least one Mcm2-7 DH ([@bib58]). This distance is also consistent with the optimal distance between the two ACSs for a functional cooperation in pre-RC complex formation *in vitro* ([@bib13]). We show that, presumably because of the average lower affinity of ORC binding to the secondary ACS, transcription termination does not occur upstream of the latter but within the ARS, where RNAPII could favor the translocation of one Mcm2-7 hexamer towards the other, or 'push' a pre-RC intermediate ([@bib76]) or the DH away or against the high affinity ORC binding site. On a case-by-case basis, it can be envisioned that antisense transcription might participate to the specification of the position of licensing factors ([@bib4]).

Functional implications for pervasive transcription at ARS {#s3-4}
----------------------------------------------------------

As highlighted above, early studies examined the impact of transcription on origin function by driving strong transcription through candidate ARSs ([@bib46]; [@bib65]; [@bib10]; [@bib30]), or estimated the transcriptional output at ARSs based on the relative orientation of stable annotated transcripts ([@bib47]; [@bib17]). To the light of the recent, more extensive appreciation of the transcriptional landscape, these studies did not address the impact of local, physiological levels of transcription on origin function. Our results demonstrate that the predominant presence of replication origins at the 3\'-ends of annotated genes or upstream of promoters in the *S. cerevisiae* genome ([@bib39]; [@bib47]; [@bib17]) does not preclude ARS from being challenged by transcription. Rather, pervasive transcription is likely to play an important role in fine-tuning origin function and influence their efficiency and the timing of activation. Similar conclusions have been recently reported in an independent study by [@bib66].

The licensing of origin is predominantly sensitive to transcription within the ARS, which might have been expected. The presence of transcribing polymerases might prevent pre-RC assembly or ORC binding to the ACS ([@bib44]; [@bib38]). Transcription through promoters has been shown to inhibit de novo transcription initiation by increasing nucleosome occupancy in these regions and lead to the establishment of chromatin marks characteristic of elongating transcription. We propose that transcription though origins might induce similar changes that are susceptible to outcompete binding of ORC and/or pre-RC formation.

Once licensing has occurred, firing ensues a series of steps leading to Mcm2-7 DH activation. It was surprising to observe that firing once licensing has occurred is also sensitive to the levels of local pervasive transcription, possibly implying that post-licensing activation steps are also somehow sensitive to the presence of transcribing RNAPII. An alternative, interesting possibility is that transcription complexes might push the Mcm2-7 DH away from the main site of initiation ([@bib22]). As a consequence, the actual position of replication initiation would be altered with a given frequency: replication might still initiate but in a more dispersed manner around the origin and would not be taken into consideration in the computation of initiation events. A final possibility is that pre-RC formation is to some extent reversible, and transcription might alter the equilibrium by occupying ARS sequences at a post-licensing but pre-activation step. The subset of origins that we found to be insensitive to transcription might be less prone to sliding or have a slower rate of pre-RC disassembly, which would make them less likely to be influenced by transcription.

The topological organization of replication origins and transcription units has been studied in many organisms, with the general consensus that the replication program is relatively flexible and adapts to the changing transcriptional environment during development or cellular differentiation in multicellular organisms ([@bib56]; [@bib51]; [@bib55]). The rapidly dividing *S.cerevisiae* has maintained some of this adaptation of replication to the needs of transcription, for example during meiotic differentiation ([@bib7]). Origin specification, nonetheless, relies on a relatively strict requirement for defined ARS sequences, which is possibly more efficient, but also less flexible for adapting to alterations in the transcription program and more sensitive to pervasive transcription. Transcription termination and RNAPII pausing at origin borders are some of the strategies that shape the local pervasive transcription landscape to the profit of origin function, and mute disruptive interferences into fine tuning of origin efficiency and activity.

Materials and methods {#s4}
=====================

Yeast strains - oligonucleotides - plasmids {#s4-1}
-------------------------------------------

Yeast strains, oligonucleotides and plasmids used in this study are reported in Table 1.

Metagene analyses {#s4-2}
-----------------

### RNAPII occupancy {#s4-2-1}

For each feature included in the analysis, we extracted the polymerase occupancy values at every position around the feature and plotted the median over all the values for that position in the final aggregate plot.

### Transcription termination around origins {#s4-2-2}

To estimate the extent of transcription termination around replication origins, we considered the detection of 3\'-ends of polyadenylated transcripts as a proxy for termination events. We counted, for each position, the number of origins for which at least one 3\'-end could be mapped at that position. We then plotted the final score per-position in the aggregate plot. This allowed considering the occurrence of at least one termination event at a given position while minimizing the impact of the steady state level of the transcripts produced by termination. To assess the statistical significance of the peak observed upstream of the primary ACS, we adopted the H0 hypothesis that termination occurs with the same frequency in the whole region of alignment around the origin. We estimated the expected value based on the frequency of termination events (i.e. presence of at least one 3'-end) in a 100nt window located at position −500 from the primary ACS across all available sites. Using this estimate, we calculated the probability of detecting the number of termination events actually observed at every position using the binomial distribution and correcting for the multiple testing factor ([@bib5]).

### Analysis of termination at ORC-ACS and nr-ACS {#s4-2-3}

ORC-ACSs are defined as the best match to the consensus under ORC ChIP peaks ([@bib19]). nr-ACSs are defined as sequences containing a nearly identical motif that are not occupied by ORC as defined by ChIP analysis ([@bib19]).

Correlation between transcription and replication metrics {#s4-3}
---------------------------------------------------------

For the boxplot analyses shown in [Figure 5](#fig5){ref-type="fig"}, we selected 190 origins out of the 228 described in [@bib48] for which replication metrics were available ([@bib25]) and considered the RNAPII read counts in the 100nt following the 5' end of the ACS, in the sense and antisense direction ([Supplementary file 1](#supp1){ref-type="supplementary-material"} Table 1). Origins were ranked based on the transcription levels to establish two groups, one of high and one of low transcription, which were compared in terms of licensing and firing efficiencies. A Student t-test (two tailed, same variance, unpaired samples) was used to estimate the statistical significance of the differences between the two distributions of values.

For the correlation analyses shown in [Figure 6](#fig6){ref-type="fig"}, we selected origins with the highest levels of incoming transcription by considering a total coverage higher than 10 read counts in an area of 200 bp upstream of the area of origin activity, both on the T-rich and A-rich strand of the ACS consensus sequence (regions 'A' and 'C', [Figure 5](#fig5){ref-type="fig"}) ([Supplementary file 1](#supp1){ref-type="supplementary-material"} Table 2). Then we summed the total read coverage over the area of origin activity (region 'B', [Figure 5](#fig5){ref-type="fig"}) on both sense and antisense strand ([Supplementary file 1](#supp1){ref-type="supplementary-material"} Table 3). This value was then correlated with different measures of replication activity.

Secondary ACS mapping {#s4-4}
---------------------

The coordinates of the predicted secondary ACSs are reported in Table 2. To map putative secondary ACS sequences, we considered a nucleotide frequency matrix for the ACS consensus sequence ([@bib13]) and produced a PWM (*P*osition *W*eight *M*atrix) using the function PWM from the R Bioconductor package 'biostrings' using default options. We used the 'matchPWM' function from 'biostrings' to look for the best match for putative secondary ACSs in the range between the position +10 to+400 relative to the main ACS. We then calculated the distribution of distances between the main and the putative secondary ACSs and the distribution of matching scores ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). For the meta-analyses shown in [Figure 1D--E](#fig1){ref-type="fig"}, we restricted this analysis to a shorter range, considering that secondary ACSs located less than 70nt or more than 200nt might not be biologically significant. The position and scores of all putative sense and antisense ACSs used for the metaanalyses are shown in Table 2.

Plasmid constructions {#s4-5}
---------------------

Oligonucleotides used for cloning and plasmids raised are reported in Table 1. P~TETOFF~-*HSP104::ARS305::HSP104* P~GAL1~-*CUP1* (*2µ*, *URA3*) plasmids were constructed by inserting a 548 bp fragment containing the wild-type *ARS305*, as defined in OriDB v2.1.0 (<http://cerevisiae.oridb.org>; chrIII:39,158--39,706) in vector pDL454 ([@bib52]) by homologous recombination in yeast cells. *ARS305* was PCR amplified from genomic DNA using primers DL3370 and DL3371 ([Figure 3B](#fig3){ref-type="fig"}) or DL3581 and DL3583 ([Figure 3C](#fig3){ref-type="fig"}). Mutations in *ARS305* were obtained by inserting linkers by stitching PCR and homologous recombination in yeast in regions A, B1 and B4 corresponding to Lin4, Lin22 and Lin102, respectively ([@bib27]).

P~TETOFF~-*HSP104-ARS1206* (pDL214) plasmid was constructed by inserting the *HSP104* gene and the downstream genomic region containing the *HSP104* terminator and *ARS1206* into pCM188 (ARS1, *CEN4*, *URA3*) by homologous recombination in yeast. ARS1 was removed from pDL214 by cleavage with NheI and repaired by homologous recombination using a fragment lacking ARS1 to obtain 'pS'. P~TETOFF~-*HSP104-6021sra* (or 'pAS') was constructed by reversing *ARS1206* orientation in 'pS' using homologous recombination in yeast.

RNA analyses {#s4-6}
------------

RNAs were prepared by the hot phenol method as previously described ([@bib35]). Northern blot analyses were performed with current protocols and membranes were hybridized to the indicated radiolabeled probe (5\'-end labelled oligonucleotide probes or PCR fragments labeled by random-priming in ULTRAhyb-Oligo or ULTRAhyb ultrasensitive hybridization buffers (Ambion)) at 42°C overnight. Oligonucleotides used for generating labeled probes are reported in Table 1. RNase H cleavage was performed by annealing 50pmoles of each oligonucleotide to 20 µg of total RNAs in 1X RNase H buffer (NEB) followed by addition of 2U of RNase H (NEB) and incubation at 30°C for 45 min. Reaction was stopped by addition of 200 mM sodium-acetate pH 5.5 and cleavage products were phenol extracted and ethanol precipitated. Pellets were resuspended in one volume of Northern sample loading buffer and the equivalent of 10 µg of total RNAs were analyzed by Northern blot on a 2% TBE1X agarose gel. Oligonucleotides used for RNase H cleavage assay are reported in Table 1.

For RT-qPCR analyses, RNAs were reverse transcribed with 200U of M-MLV reverse transcriptase (ThermoFisher) and strand specific primers for 45 min at 37°C. Reactions were diluted 10 times before qPCR analyses. Quantitative PCRs were performed on a LightCycler 480 (Roche) in 384-Multiwell plates (Roche) in 10 µL reactions that contained 1% of the reverse transcription mix and 0.25 pmoles of each priming oligonucleotides. Quantification was performed using the ∆∆Ct method. 'No RT' controls were systematically analyzed in parallel. Each transcription level reported represents the mean of three independent RNA extractions each assayed in duplicate qPCRs. Error bars represent standard deviations. Oligonucleotides used for RT-qPCR are reported in Table 1. Unless indicated otherwise, transcription levels were normalized to *ACT1* mRNA levels.

Plasmid-loss assay {#s4-7}
------------------

Cells were transformed with the indicated *ARS1206*-borne (*CEN4*, *URA3*) plasmid and plated on complete synthetic medium lacking uracile. Single transformants were used to inoculate liquid cultures of CSM −URA that were grown to saturation. Saturated cultures were back diluted into rich medium and maintained in logarythmic phase (i.e. below 0.8 OD~600~) for the indicated number of generations. Aliquots were pelleted, rinsed with water and seven-fold serial dilutions were spotted on YPD and CSM −URA, starting at 0.3 OD~600~. Growth on YPD plates was used to infer that the same numbers of cells were spotted, while reduced numbers of cells growing on CSM−URA reflected plasmid loss over the indicated number of generations.

Datasets {#s4-8}
--------

Datasets used in this study are available from GEO with accession numbers GSE56435 ([@bib63]), GSE75586 ([@bib60]) and GSE97913 ([@bib9]).

Tables {#s4-9}
------

[Table 1](#table1){ref-type="table"} and [Table 2](#table2){ref-type="table"}.
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###### Yeast strains, oligonucleotides and plasmids used in this work. 

  ------------------ ---------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -----------------------------------------------------------------------------------------------------
  Yeast strains      Name                                                                               Genotype                                                                                                                                                                                                                                                 **Origin**

   DLY671            *W303-1a trp1∆*                                                                    Libri laboratory (BMA64)                                                                                                                                                                                                                                 

   DLY2923           *W303-1a ORC2 ORC5 CDC6*                                                           Gift from the Pasero laboratory (PP2583)                                                                                                                                                                                                                 

   DLY2685           *As W303-1a, ORC2 ORC5 cdc6-1*                                                     Gift from the Schwob laboratory (E589)                                                                                                                                                                                                                   

   DLY2687           *As W303-1a, orc2-1 ORC5 CDC6*                                                     Gift from the Schwob laboratory (E1507)                                                                                                                                                                                                                  

   DLY2688           *As W303-1a, ORC2 orc5-1 CDC6*                                                     Gift from the Schwob laboratory (E4649)                                                                                                                                                                                                                  

  Oligonucleotides   Name                                                                               Sequence                                                                                                                                                                                                                                                 **Purpose**

   DL3370            CATCCACAATTACAACCTATACATATTCTAGCTGCCTTCATTGAAACGGCGACGCCCGACGCCGTAATAAC            Amplification of ARS305 from genomic DNA. Fw primer bearing 48 bp of homology with DL1702.                                                                                                                                                               

   DL3371            gaatctttcttcgaaatcacctttgtatttagcacctgcggttaatgcggATATATCAGAAACATACATATG           Amplification of ARS305 from genomic DNA. Rev primer bearing 50 bp of homology with DL1666.                                                                                                                                                              

   DL3446            CATCCACAATTACAACCTATACATATTCTAGCTGCCTTCATTGAAACGATATATCAGAAA\                      Insertion of ARS305 in reverse orientation\                                                                                                                                                                                                              
                     CATACATATG                                                                         (compare with primer pair DL3370/DL3371). Rev primer bearing homology with DL1702.                                                                                                                                                                       

   DL3447            gaatctttcttcgaaatcacctttgtatttagcacctgcggttaatgcggGCG\                             Insertion of ARS305 in reverse orientation (compare with primer pair DL3370/DL3371). Fwd primer bearing homology with DL1666.                                                                                                                            
                     ACGCCCGACGCCGTAATAAC                                                                                                                                                                                                                                                                                                                        

   DL3581            gaatctttcttcgaaatcacctttgtatttagcacctgcggttaatgcggGTTTCATGTACTGTCCGGTGTGATT        Insertion of shortened ARS305, fwd (cf. DL3447). Primes 32 bp downstream B4 element, removing 291 bp of ARS305 "full-length "3' end.                                                                                                                     

   DL3583            CATCCACAATTACAACCTATACATATTCTAGCTGCCTTCATTGAAACGGAGTATTTGATCCTTTTTTTTATTGTG        Insertion of shortened ARS305, rev (cf. DL3446). Primes 34 bp upstream ARS305 ACS, removing 83 bp of ARS305\                                                                                                                                             
                                                                                                        "full-length "5' end.                                                                                                                                                                                                                                    

   DL3376            TTATTCCTCGAGGACTTTGTAGTTCTTAAAGC                                                   Insertion of linker substitution Lin102 (B4-) in ARS305 by two stages overlapping PCRs.\                                                                                                                                                                 
                                                                                                        Fw primer,\                                                                                                                                                                                                                                              
                                                                                                        pair with DL3371.                                                                                                                                                                                                                                        

   DL3377            CTACAAAGTCCTCGAGGAATAATAAATCACACCGGAC                                              Insertion of linker substitution Lin102 (B4-) in ARS305 by two stages overlapping PCRs. Rev primer, pair with DL3370.                                                                                                                                    

   DL3378            GGGACCTCGAGGAATACATAACAAAACATATAAAAACC                                             Insertion of linker substitution Lin22 (B1-) in ARS305 by two stages overlapping PCRs. Fw primer, pair with DL3371.                                                                                                                                      

   DL3379            GTTATGTATTCCTCGAGGTCCCTTTAATTTTAGGATATG                                            Insertion of linker substitution Lin22 (B1-) in ARS305 by two stages overlapping PCRs. Rev primer, pair with DL3370.                                                                                                                                     

   DL3380            CATAACCCTCGAGGTAAAAACCAACACAATAAAAAAAAGG                                           Insertion of linker substitution Lin4 (A-) in ARS305 by two stages overlapping PCRs. Fw primer, pair with DL3371.                                                                                                                                        

   DL3381            GGTTTTTACCTCGAGGGTTATGTATTGTTTATTTTCC                                              Insertion of linker substitution Lin4 (A-) in ARS305 by two stages overlapping PCRs. Rev primer, pair with DL3370.                                                                                                                                       

   DL1359            CCTTATACATTAGGTCCTTT                                                               *HSP104* Northern PCR probe, fwd. Primes about 100nt upstream *HSP104* ATG in PTE\                                                                                                                                                                       
                                                                                                        TOFF-*HSP104* plasmid serie                                                                                                                                                                                                                              

   DL1360            ATCCCCCGAATTGATCCGG                                                                *HSP104* Northern PCR probe, rev. Primes upstream BamHI site in PTETOFF-*HSP104* plasmid serie                                                                                                                                                           

   DL377             ATGTTCCCAGGTATTGCCGA                                                               *ACT1* Northern PCR probe/RT qPCR amplicon, fwd.                                                                                                                                                                                                         

  Oligonucleotides    DL378                                                                             acacttgtggtgaacgatag                                                                                                                                                                                                                                     *ACT1* Northern PCR probe/RT qPCR amplicon, rev.

   DL2627            ATTCAAAAGCGAACACCGAATTGACCATGAGGAGACGGTCTGGTTTAT                                   *snR14* Northern oligo probe                                                                                                                                                                                                                             

   DL3763            CTGGTTGAAACAAATCAGTGCCGGTAAC                                                       ARS404 qRT-PCR,\                                                                                                                                                                                                                                         
                                                                                                        amplicon downstream ARS404 ACS. 5' primes 202 bp\                                                                                                                                                                                                        
                                                                                                        after SSB1 STOP, pair with DL3764.                                                                                                                                                                                                                       

   DL3764            GACTTTTTCTTAACTAGAATGCTGGAGTAGAAATACGC                                             ARS404 qRT-PCR, amplicon downstream ARS404 ACS. 5' primes 288 bp after SSB1 STOP, pair with DL3763.                                                                                                                                                      

   DL3767            CTTTTTAAACTAATATACACATTTTAGCAGATGCG                                                ARS404 qRT-PCR,\                                                                                                                                                                                                                                         
                                                                                                        amplicon upstream ARS404 ACS. 5' primes 23 bp\                                                                                                                                                                                                           
                                                                                                        after HO STOP, pair with DL3768.                                                                                                                                                                                                                         

   DL3768            GATGCTGTCCGCGGGCCTCATAAG                                                           ARS404 qRT-PCR, amplicon upstream ARS404 ACS. 5' primes60 bp before HO STOP, pair with DL3767.                                                                                                                                                           

   DL3823            GGCACTATGCTTTTTAAAATTTTGTTTATACTCAATTTCG                                           ARS1004 qRT-PCR, amplicon upstream\                                                                                                                                                                                                                      
                                                                                                        ARS1004 ACS. 5' anneals80 bp after REE1 STOP                                                                                                                                                                                                             

   DL3824            GCCCAGTATTTTGTTAACTGTATGGATTGTACTAG                                                ARS1004 qRT-PCR, amplicon upstream ARS1004 ACS. 5' anneals170 bp after REE1 STOP                                                                                                                                                                         

   DL3827            GTGTTTTAAGATAAAGTGACGAAAGTTAGGGTG                                                  ARS1004 qRT-PCR, amplicon downstream ARS1004 ACS. 5' anneals 228 bp after REE1 STOP                                                                                                                                                                      

   DL3828            CATCATAAGTACTAATTACCACGAATTCAATAATTAGTAAATAC                                       ARS1004 qRT-PCR, amplicon downstream ARS1004 ACS. 5' anneals 318 bp after REE1 STOP                                                                                                                                                                      

   DL187             ACACActaaattaccggatcaattcgggggatccATGAACGACCAAACGCAATT                             Cloning of *HSP104* in pCM188, fwd.                                                                                                                                                                                                                      

   DL189             catgatgcggccctcctgcagggccctagcggccgcTTAATCTAGGTCATCATCAA                           Cloning of *HSP104* in pCM188, rev.                                                                                                                                                                                                                      

   DL1124            taatgaggacagtatggaaattgatgatgacctagattaaTTTAATATAGTGTGATTTTT                       Cloning of *HSP104* 3\' UTR in pCM188-*HSP104*, fwd.                                                                                                                                                                                                     

   DL1125            ATTACATGATGCGGCCCTCCTGCAGGGCCCTAGCGGCCGCTTTAACATGATTTGGTAGTC                       Cloning of *HSP104* 3\' UTR in pCM188-*HSP104*, fwd.                                                                                                                                                                                                     

   DL4026            CGTTTATTCCCTTGTTTGATTCAGAAGCAG                                                     ARS1 KO in pDL214 by\                                                                                                                                                                                                                                    
                                                                                                        overlapping PCRs, Fwd. Anneals 236 bp after pDL214's\                                                                                                                                                                                                    
                                                                                                        *URA3* STOP. To be used for both 1 st and 2nd step of the reaction.\                                                                                                                                                                                     
                                                                                                        During 1 st step, use it in combination with DL4027. During 2nd step, use it in combination with DL4030.                                                                                                                                                 

  Oligonucleotides    DL4027                                                                            GCTAGCAAGAATCGGCTCGGGGCTCTCTTGCCTTCCAAC                                                                                                                                                                                                                  ARS1 KO in pDL214 by overlapping PCRs, Rev. Anneals 334 bp after pDL214's *URA3* STOP.\
                                                                                                                                                                                                                                                                                                                                                                 To be used during 1 st step in combination with DL4026.

   DL4029            CAAGAGAGCCCCGAGCCGATTCTTGCTAGCCTTTTCTC                                             ARS1 KO in pDL214 by overlapping PCRs, Fwd. Anneals 746 bp after pDL214's *URA3* STOP. To be used during 1 st step in combination with DL4030.                                                                                                           

   DL4030            GATTACGAGGATACGGAGAGAGG                                                            ARS1 KO in pDL214 by overlapping PCRs, Rev. Anneals 843 bp after pDL214's *URA3* STOP. To be used for both 1 st and 2nd step of the reaction. During 1 st step, use it in combination with DL4029. During 2nd step, use it in combination with DL4026.   

   DL4032            GTGAAGGAGCATGTTCGGCACAC                                                            ARS1 KO in pDL214 by overlapping PCRs, Rev sequencing primer. Anneals 1157 bp after pDL214's *URA3* STOP.                                                                                                                                                

   DL4000            TTCAAATGTACAGTAACTATCAAAACCATT\                                                    Reverse ARS1206 orientation in pDL214, Fwd.\                                                                                                                                                                                                             
                     ATTGTAGTACCCGTATTCTAATAATGAGCAAAAGAGCTCACATTTTAACG                                 Bears 55 bp of homology with ARS1206 3' end (+320 to+375 after *HSP104* STOP) followed by 25 bp of homology\                                                                                                                                             
                                                                                                        to 5' of T-rich predicted ACS (+102 to+127 after *HSP104* STOP). Pair with DL4001.                                                                                                                                                                       

   DL4001            TATATATAATTAATAAAACTAATGGAATTTGTTTAATTGAACTTGACACCCGAGCGGACCAATCCGCGTGTGTTTTATAC   Reverse ARS1206 orientation in pDL214, Rev. Bears 55 bp\                                                                                                                                                                                                 
                                                                                                        of homology with ARS1206 5' end (+51 to+106 after *HSP104* STOP) followed by 25 bp of homology with 3' end of ARS1206 (+295 to+320 after *HSP104* STOP). Pair with DL4000.                                                                               

   DL4061            ATTATTAGAATACGGGTACTAC                                                             Reverse ARS1206 orientation in pDL214, extension of homology region downstream ARS1206, Fwd. Primes 134 bp upstream *CYC1* terminator. Pair with M13 reverse (DL2163).                                                                                   

   DL2163            caggaaacagctatgac                                                                  Reverse ARS1206 orientation in pDL214, extension of homology region downstream ARS1206, Rev.                                                                                                                                                             

   DL4066            GCTCGGGTGTCAAGTTCAATTAAAC                                                          Reverse ARS1206 orientation in pDL214, extension of homology region\                                                                                                                                                                                     
                                                                                                        upstream ARS1206, Rev. Primes 106 bp downstream *HSP104* STOP. Pair with DL530.                                                                                                                                                                          

   DL530             GTTGAATTTAACTCAAGAGGC                                                              Reverse ARS1206 orientation in pDL214, extension of homology region upstream ARS1206, Fwd. Anneals 2409--2429 in\                                                                                                                                        
                                                                                                        *HSP104*.                                                                                                                                                                                                                                                

  Oligonucleotides    DL3986                                                                            gctgaagaatgtctggaagttctacc                                                                                                                                                                                                                               Reverse ARS1206 orientation in pDL214, Fwd sequencing primer annealing 108 bp before *HSP104* STOP.

   DL163             acattttcatcacgagatttaccc                                                           RNase H cleavage assay. *HSP104*, antisense, position 2606--2583\                                                                                                                                                                                        
                                                                                                        from *HSP104* ATG.                                                                                                                                                                                                                                       

   DL164             ttatcgtcatcacctaacgtgtcagcccctatagtagcttcgtgatttggtagaacttcc                       RNase H cleavage assay. *HSP104* Northern oligonucleotide probe, antisense, position 2718--2631 from *HSP104* ATG.                                                                                                                                       

   DL473             TTTTTTTTTTT\                                                                       RNase H cleavage assay. Poly(dT) oligonucleotide                                                                                                                                                                                                         
                     TTTTTTTTT                                                                                                                                                                                                                                                                                                                                   

   DL3991            GATTTGACGTCCAGTGGACTTTTTTGTCC                                                      RNase H cleavage assay, test*HSP104* readthrough on pDL905, antisense, position 2923--2895 from*HSP104* ATG                                                                                                                                              

   DL3994            GGAAGTAATAAGTGAAGGTTAAATCTGGACC                                                    RNase H cleavage assay, test *HSP104* readthrough on pDL907, antisense, position 2909--2879 from *HSP104* ATG                                                                                                                                            

   Plasmids          Name                                                                               Features                                                                                                                                                                                                                                                 **Reference**

   pDL454            PTETOFF-HSP104::Reb1BS::HSP104, PGAL1-\                                            Colin et al. [@bib12]                                                                                                                                                                                                                                    
                     CUP1, 2µ, URA3                                                                                                                                                                                                                                                                                                                              

   pDL551            PTETOFF-HSP104::\                                                                                                                                                                                                                                                                                                                           
                     Reb1BS(−)::HSP104, PGAL1-\                                                                                                                                                                                                                                                                                                                  
                     CUP1, 2µ, URA3                                                                                                                                                                                                                                                                                                                              

   pDL790            PTETOFF-HSP104::ARS305_548 bp::HSP104\                                             This study                                                                                                                                                                                                                                               
                     , PGAL1-CUP1, 2µ, URA3                                                                                                                                                                                                                                                                                                                      

   pDL793            PTETOFF-HSP104::ARS305(A−)\_548 bp::HSP104,\                                                                                                                                                                                                                                                                                                
                     PGAL1-CUP1, 2µ, URA3                                                                                                                                                                                                                                                                                                                        

   pDL909            PTETOFF-HSP104::\                                                                                                                                                                                                                                                                                                                           
                     ARS305_175 bp::HSP104,\                                                                                                                                                                                                                                                                                                                     
                     PGAL1-CUP1, 2µ, URA3                                                                                                                                                                                                                                                                                                                        

   pDL910            PTETOFF-HSP104::\                                                                                                                                                                                                                                                                                                                           
                     ARS305(A−)\_175 bp::HSP104,\                                                                                                                                                                                                                                                                                                                
                     PGAL1-CUP1, 2µ, URA3                                                                                                                                                                                                                                                                                                                        

   pDL911            PTETOFF-HSP104::ARS305(B1−)\_175 bp::HSP104, PGAL1-CUP1, 2µ, URA3                                                                                                                                                                                                                                                                           

   pDL912            PTETOFF-HSP104\                                                                                                                                                                                                                                                                                                                             
                     ::ARS305(B4−)\_175 bp::HSP104\                                                                                                                                                                                                                                                                                                              
                     , PGAL1-CUP1, 2µ, URA3                                                                                                                                                                                                                                                                                                                      

   pDL913            PTETOFF-HSP104\                                                                                                                                                                                                                                                                                                                             
                     ::ARS305(B1−B4−)\_175 bp::HSP104,\                                                                                                                                                                                                                                                                                                          
                     PGAL1-CUP1, 2µ, URA3                                                                                                                                                                                                                                                                                                                        

   pDL30             PTETOFF-HSP104,\                                                                   Libri laboratory                                                                                                                                                                                                                                         
                     ARS1, CEN4, URA3                                                                                                                                                                                                                                                                                                                            

   pDL214            PTETOFF-HSP104,\                                                                                                                                                                                                                                                                                                                            
                     ARS1206, ARS1, CEN4, URA3                                                                                                                                                                                                                                                                                                                   

   pDL905            PTETOFF-HSP104, ARS1206, ∆ars1, CEN4, URA3                                         This study                                                                                                                                                                                                                                               

   pDL907            PTETOFF-HSP104, 6021sra, ∆ars1, CEN4, URA3                                                                                                                                                                                                                                                                                                  
  ------------------ ---------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -----------------------------------------------------------------------------------------------------
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###### Coordinates of primary and secondary ACSs used in this study. 

        Proposed primary ACS ([@bib48])   Putative secondary ACS (this study)                                                                                                                              
  ----- --------------------------------- ------------------------------------- --------- --------- ------------------- ------------- --------- ---- --------- --------- ------------------- ------------- -----
  1     chrI                              \+                                    31001     31018     TATTTTTAAGTTTTGTT   0.974909231   chrI      \-   31190     31173     GTATAATATTTTTAGTT   0.87301127    189
  2     chrI                              \-                                    70431     70414     ATTTTTTATGTTTAGAA   0.949548431   chrI      \+   70251     70268     ACTATCAATGTTTTATC   0.818662772   180
  3     chrI                              \-                                    124526    124509    ATTTTTTATATTTAAGT   0.939615332   chrI      \+   124412    124429    GTTTTCTCTATTTAAAT   0.76163459    114
  4     chrI                              \+                                    159951    159968    TTTATTTATATTTAGTG   0.951660057   chrI      \-   160108    160091    ATATAGCATAATTACTT   0.796339361   157
  5     chrI                              \+                                    176234    176251    TCTTTTTATGTTTTCTT   0.936946746   chrI      \-   176333    176316    TAAATATGTGTTTATTA   0.816621821   99
  6     chrII                             \+                                    28984     29001     TCACTCTATCTTTTTTA   0.78989004    chrII     \-   29092     29075     TATAACAAAAATTGGTC   0.767973746   108
  7     chrII                             \-                                    63376     63359     TTTTTTTAATTTTTGTC   0.934538928   chrII     \+   63256     63273     TAAAAATTTGTTTTCTT   0.843331211   120
  8     chrII                             \-                                    170228    170211    CCAGTGAACGCTTAAAA   0.646819795   chrII     \+   170126    170143    CTTTGCTACGATTTCTT   0.763191826   102
  9     chrII                             \-                                    198382    198365    AACTTCAAAGTACATTG   0.673812699   chrII     \+   198228    198245    ATTATAGACTTTCATTC   0.772245255   154
  10    chrII                             \-                                    237832    237815    AAGGTACATAGCGATTT   0.628400298   chrII     \+   237685    237702    TTATTAAAGGGTTTGGA   0.774836934   147
  11    chrII                             \-                                    255040    255023    AGGTAGAAGAGTTACGG   0.617416402   chrII     \+   254892    254909    TGATTTTTCATTTTACT   0.841326164   148
  12    chrII                             \+                                    326149    326166    CTATCGAAACTTTTGTT   0.748562634   chrII     \-   326273    326256    CTTTTAATAGTTTAGGT   0.860235002   124
  13    chrII                             \-                                    408006    407989    TAGGAAAATATATAGAG   0.708025047   chrII     \+   407871    407888    ATATTTAAAGAGTTGAA   0.77590664    135
  14    chrII                             \-                                    417974    417957    TGTAGAAATGTCTAGCG   0.67916971    chrII     \+   417844    417861    AAATTTAATATTTTTGA   0.912902242   130
  15    chrII                             \-                                    486855    486838    GAAGTCCTCTTCTTCGC   0.639951668   chrII     \+   486735    486752    ATTAATTATGTTTTTCC   0.89533109    120
  16    chrII                             \+                                    622713    622730    TATATAGAAAGTTGCTT   0.760778109   chrII     \-   622866    622849    TTTTTGTACGTTTTTTT   0.907808059   153
  17    chrII                             \+                                    704289    704306    CTACCAAAAGTGTACCG   0.581803503   chrII     \-   704455    704438    AATGTTTTTTTTTTTTT   0.897759223   166
  18    chrII                             \-                                    741746    741729    CGAAAAGATATGTGGGA   0.64946824    chrII     \+   741628    741645    TAAGATCAAGTTTGGTA   0.824844021   118
  19    chrII                             \+                                    757441    757458    TAAATCTAAGATAGCTG   0.682422088   chrII     \-   757613    757596    GTTATATAAGTATACGT   0.779064174   172
  20    chrII                             \+                                    792164    792181    TATTTCATGGTTTTTAG   0.736834685   chrII     \-   792287    792270    CTTTTTAAAATTCATTG   0.834945362   123
  21    chrIII                            \+                                    11254     11271     TTTTTTTATGTTTTTTT   0.985847127   chrIII    \-   11400     11383     GTTGAATTTGGTTAGAT   0.782826917   146
  22    chrIII                            \-                                    39591     39574     TTTTTATATGTTTTGTT   0.963617028   chrIII    \+   39476     39493     TTATTTTTTATTTACTT   0.914777509   115
  23    chrIII                            \+                                    74518     74535     TGTATTTATATTTATTT   0.944792175   chrIII    \-   74682     74665     GAGATCTTAATTTATCT   0.770457519   164
  24    chrIII                            \-                                    108972    108955    TTTATTTATGTTTTCTT   0.960865701   chrIII    \+   108832    108849    TAGAAATATGTTGAGTT   0.795588546   140
  25    chrIII                            \+                                    132036    132053    TTTGTACATTGTTTATA   0.792015393   chrIII    \-   132155    132138    CTTTTATATGTTTAAAT   0.885104513   119
  26    chrIII                            \+                                    166650    166667    GTTTTATTCCATTATTT   0.81768767    chrIII    \-   166768    166751    ATTATTTACATTTACGA   0.903103359   118
  27    chrIII                            \+                                    194302    194319    CTACTGCAATTTTTTAC   0.730959168   chrIII    \-   194402    194385    TGTAATTACATTTCTTA   0.79211775    100
  28    chrIII                            \-                                    197559    197542    AATATTCATGTTTAGTA   0.934784063   chrIII    \+   197415    197432    ATCTTAAACCTTTTTAG   0.797219912   144
  29    chrIII                            \+                                    224856    224873    TCAGTTTTTTTTATGTT   0.78153895    chrIII    \-   224956    224939    TTTATTTTTGTTTGTTT   0.899494022   100
  30    chrIII                            \-                                    273030    273013    TTTTTTCAAATTTAGTT   0.94325972    chrIII    \+   272904    272921    TTTATTCAAAATTTTTC   0.870692365   126
  31    chrIII                            \+                                    292584    292601    TATATATATATTTATTT   0.933162383   chrIII    \-   292695    292678    TATAATAACATTTTTTA   0.881496782   111
  32    chrIII                            \+                                    315872    315889    TGTATATAAATTAAGTG   0.777607317   chrIII    \-   315979    315962    CATTTTAATATCTATAT   0.829435873   107
  33    chrIV                             \-                                    15681     15664     ATTTTTTACGTTTTCTC   0.928797007   chrIV     \+   15525     15542     TAAATTCTAAGTTATTC   0.806599978   156
  34    chrIV                             \-                                    86123     86106     GATTTTTATGTTTGGGC   0.907628171   chrIV     \+   85996     86013     CTTTATAAAGATTTTAT   0.843543061   127
  35    chrIV                             \+                                    123677    123694    TGTTTTCACTTTGTGTT   0.820618605   chrIV     \-   123793    123776    TTAATATATATTTAGTT   0.9347773     116
  36    chrIV                             \-                                    212592    212575    TTTTTTTATATTTTGTT   0.991320747   chrIV     \+   212441    212458    TTTTTTTTTTTTTTTTT   0.926463613   151
  37    chrIV                             \+                                    253839    253856    ATTTTTTATAGTTTTGC   0.901024131   chrIV     \-   253948    253931    TAATTTTATCTTTAGAT   0.940018266   109
  38    chrIV                             \-                                    329742    329725    GATTTTTATTTTTTTGT   0.930581986   chrIV     \+   329601    329618    TATTATTATTATTATTC   0.884653435   141
  39    chrIV                             \+                                    408134    408151    TTATATTATATTTAGCG   0.896228674   chrIV     \-   408291    408274    TTATTACATATTTTTGT   0.898263462   157
  40    chrIV                             \-                                    484039    484022    TTTTTTTATATTTATGT   0.972409126   chrIV     \+   483896    483913    TTGTTTGTTCATTTCTT   0.792451309   143
  41    chrIV                             \-                                    505522    505505    TTTTTTTATATTTTTGC   0.95203234    chrIV     \+   505345    505362    CCTTTTCACGTTTTTGC   0.864843823   177
  42    chrIV                             \-                                    555401    555384    AAAGTTTATGTTTTTTC   0.925775335   chrIV     \+   555290    555307    ATAAATGTTGTTTTTTT   0.835510567   111
  43    chrIV                             \-                                    567681    567664    TTTTTTTATGTTTTGAG   0.946669447   chrIV     \+   567572    567589    ACTTTTAATTTTTTTTT   0.905571442   109
  44    chrIV                             \-                                    640068    640051    TTTTTTAAAGTTTTGGT   0.951500543   chrIV     \+   639918    639935    CTATAATATATTTATTC   0.86149187    150
  45    chrIV                             \+                                    702928    702945    AAAATAATTAATGTTTT   0.737939741   chrIV     \-   703030    703013    TGATTTAAAATTCTGTA   0.83908476    102
  46    chrIV                             \+                                    748452    748469    AAATTAATTGATTAATT   0.822458971   chrIV     \-   748585    748568    TTTTTTAATATTTAATA   0.915446997   133
  47    chrIV                             \-                                    753339    753322    TTTTTTTACATTTTGCT   0.953908195   chrIV     \+   753221    753238    AAACTTATTTTTTAAGC   0.78950557    118
  48    chrIV                             \+                                    806097    806114    CTCTTCCAAATTTTTAA   0.777746734   chrIV     \-   806256    806239    TCATATCCTGTTTTAAA   0.722790604   159
  49    chrIV                             \+                                    913859    913876    TTTTTTTATTTTTATAT   0.943491396   chrIV     \-   913957    913940    ACAATTTTTGTTTATTT   0.885371567   98
  50    chrIV                             \+                                    921736    921753    TCTTTAATCGATTTTAA   0.773941597   chrIV     \-   921840    921823    TTTGTTTATTTTTTTTT   0.943438157   104
  51    chrIV                             \-                                    1016854   1016837   TTTGTTTACGTTTTGGA   0.934312886   chrIV     \+   1016682   1016699   AGAATTCATTTTAATCT   0.772819262   172
  52    chrIV                             \+                                    1057886   1057903   TTCTTTTATTATTTTTT   0.899933367   chrIV     \-   1058017   1058000   AAAGTGAATTTTTTTGT   0.837029199   131
  53    chrIV                             \-                                    1110139   1110122   TTTTTTTATATTTTTAT   0.956467815   chrIV     \+   1109960   1109977   GAATTCTTCATTTAGAT   0.824896005   179
  54    chrIV                             \-                                    1159452   1159435   CTTTTCTAAGCTTTGAA   0.769370807   chrIV     \+   1159286   1159303   ATAATTAATTTTTTTGA   0.889208627   166
  55    chrIV                             \-                                    1166166   1166149   TCGGAATATTATTTCTT   0.763125812   chrIV     \+   1166064   1166081   CTTAATAAATTTTTGTA   0.854045557   102
  56    chrIV                             \+                                    1240920   1240937   CTTCTTGAAATTTGATT   0.771311686   chrIV     \-   1241096   1241079   TTTATAAAAATTTATAT   0.871453601   176
  57    chrIV                             \+                                    1276271   1276288   TTCGTTTTCTTTTTCTC   0.82062871    chrIV     \-   1276405   1276388   CAAATATATATTGATCA   0.767679431   134
  58    chrIV                             \-                                    1302763   1302746   TATATATTTAGTTAATG   0.795859241   chrIV     \+   1302616   1302633   GAGTTTTACGTATTCTT   0.80224896    147
  59    chrIV                             \+                                    1404323   1404340   TAAAATCATTTTCTTTT   0.829710275   chrIV     \-   1404511   1404494   AGGATTCTTTATTACGT   0.774058834   188
  60    chrIV                             \+                                    1461890   1461907   GAGTAACTTCTTGTCGG   0.624436491   chrIV     \-   1462038   1462021   AACATTAATTGTTGTTA   0.790149896   148
  61    chrIV                             \-                                    1487098   1487081   TTAAATTTAGTTTTTTT   0.870549799   chrIV     \+   1486965   1486982   CCAATACATGATTGGAT   0.773138313   133
  62    chrV                              \-                                    59469     59452     AATATTTACATTTTGAT   0.935717414   chrV      \+   59363     59380     TTTTTTTTTCTTTTTTT   0.922560213   106
  63    chrV                              \+                                    94055     94072     CAAGTTTATATTTTGTT   0.938620288   chrV      \-   94173     94156     TATGTTTAATTATATTG   0.79888376    118
  64    chrV                              \-                                    145714    145697    CAGTTTTTTGTTTAGTT   0.906995194   chrV      \+   145608    145625    TTATATAATATTTTAGG   0.854409653   106
  65    chrV                              \-                                    173808    173791    TAATTTTATATTTTGCC   0.93759113    chrV      \+   173704    173721    TATTTATACTTTTACGG   0.861582181   104
  66    chrV                              \+                                    212455    212472    TAAAATTATGTTTAGGT   0.938368393   chrV      \-   212555    212538    CGTATACTTTTTTTGTG   0.794230687   100
  67    chrV                              \+                                    287567    287584    TTTATTTATGTTTTGTT   0.988690479   chrV      \-   287761    287744    CTTTGTTATCTTGTGAA   0.729422588   194
  68    chrV                              \+                                    353586    353603    AATATTTACTTTTTGGT   0.936542643   chrV      \-   353774    353757    TTGAATTATGCTTATGT   0.812386986   188
  69    chrV                              \-                                    406906    406889    TTTTTTTATATATAGTC   0.881971164   chrV      \+   406734    406751    GTAATTTATGATTAATC   0.864888268   172
  70    chrV                              \-                                    439105    439088    ATTTTTTAAGTTTTGCG   0.915882066   chrV      \+   438997    439014    GGTATTCTTCTTTTTCT   0.814453982   108
  71    chrV                              \+                                    549589    549606    TATTATTAATATCTTGT   0.818517794   chrV      \-   549686    549669    TAATTTAATATTTTTTT   0.948482332   97
  72    chrVI                             \-                                    167738    167721    TATATTTATATTTTCGT   0.945765544   chrVI     \+   167551    167568    AATATTTAAATATAAGT   0.814242246   187
  73    chrVI                             \+                                    199397    199414    TTATTTCGAGCTTTGTC   0.737504399   chrVI     \-   199507    199490    ATCCATAATATTTACCT   0.801830214   110
  74    chrVI                             \+                                    216470    216487    CATTTCTATTTTTTTTT   0.890722071   chrVI     \-   216600    216583    TAATGTGATGGTTAGTT   0.802062704   130
  75    chrVI                             \-                                    256383    256366    TTTATGTTTTTTCCGGA   0.701845209   chrVI     \+   256263    256280    AAAAATTCCGATCTTGT   0.72753389    120
  76    chrVII                            \-                                    64458     64441     ATTTTTAATATTTTGTT   0.966859378   chrVII    \+   64357     64374     TATTGTTATATTTAGTT   0.901272249   101
  77    chrVII                            \+                                    112124    112141    ATTTTATACGTTTATGT   0.921703978   chrVII    \-   112271    112254    ATAGTTTTTTTTTATGC   0.861155565   147
  78    chrVII                            \+                                    163235    163252    TCATTTTATAATTTGTT   0.916233817   chrVII    \-   163378    163361    GTAATATATGATTAGAA   0.844307348   143
  79    chrVII                            \+                                    203971    203988    ATTTTTTATATTTATTA   0.950625858   chrVII    \-   204165    204148    CATTTTAAACTCTATAT   0.78805761    194
  80    chrVII                            \+                                    286003    286020    TTTATTTACTTTTAGTC   0.933155022   chrVII    \-   286153    286136    CTAGTAATCTTTCAGTC   0.747097252   150
  81    chrVII                            \-                                    352863    352846    TTTAATTACGTTTAGTT   0.942276914   chrVII    \+   352758    352775    TACTTTTATGATTCATT   0.812763403   105
  82    chrVII                            \-                                    388846    388829    TTTATTTAACTTTTGTT   0.939702794   chrVII    \+   388738    388755    TTAGTTCTCATTTATAA   0.82432824    108
  83    chrVII                            \-                                    421280    421263    ATAAATTATTGTTTAGT   0.826708937   chrVII    \+   421176    421193    CTATTTCAAATTTGTTT   0.859366438   104
  84    chrVII                            \-                                    485110    485093    TTTATTTATGTTTTGCC   0.947613634   chrVII    \+   484978    484995    AATTATCAAGTTTTTCT   0.875154553   132
  85    chrVII                            \-                                    508907    508890    CATTTTAATGTTTGGTT   0.923555282   chrVII    \+   508801    508818    ATCTTTTATCTTTTATC   0.872797056   106
  86    chrVII                            \-                                    568660    568643    AGTATTTATATTTAGCC   0.909439604   chrVII    \+   568509    568526    GTCATTCATGATTTATT   0.834093344   151
  87    chrVII                            \+                                    574700    574717    AGTATTTATGTTTTGTC   0.937749085   chrVII    \-   574854    574837    TATACTCATATTTTGGC   0.838055118   154
  88    chrVII                            \-                                    660000    659983    ATATTTTATGTTTACTT   0.952756007   chrVII    \+   659904    659921    TTGTTTTTTTATTGTTT   0.823819951   96
  89    chrVII                            \+                                    715314    715331    TTTGTTTATATTTTGTT   0.970567449   chrVII    \-   715431    715414    AATCTTTAACTTGTGAT   0.779912848   117
  90    chrVII                            \+                                    778013    778030    CTTTTTTACCTTTTGTT   0.938434047   chrVII    \-   778193    778176    AGTGTTTATATTTATTT   0.926919799   180
  91    chrVII                            \-                                    834664    834647    TTGTATATAGTTTAGTT   0.854509956   chrVII    \+   834549    834566    GGTTTTTAACTTTTCCC   0.830646453   115
  92    chrVII                            \+                                    888412    888429    TATTTTAATATTTTGTT   0.973625821   chrVII    \-   888567    888550    TTTATATATATATATTC   0.823335292   155
  93    chrVII                            \-                                    977904    977887    TTTTTTAATTTTTTTAT   0.925318963   chrVII    \+   977810    977827    TTTTTTTAATGATTTTT   0.806000942   94
  94    chrVII                            \+                                    999468    999485    CTTTTTTACTTTTTGGG   0.904948204   chrVII    \-   999575    999558    TATTTTTTTTTTTTTTT   0.925871289   107
  95    chrVIII                           \-                                    7755      7738      TATTTTTATATTTAGGT   0.984899843   chrVIII   \+   7618      7635      CTTGTTTATTATTATTA   0.875022851   137
  96    chrVIII                           \+                                    64302     64319     TAATTTTAATTTTAGTT   0.942262943   chrVIII   \-   64434     64417     ATTCTTTATATTTATTT   0.922675429   132
  97    chrVIII                           \-                                    133538    133521    TATTTTAACATTTAGTT   0.959052991   chrVIII   \+   133406    133423    TTCTTTTATGTGTATGC   0.834208883   132
  98    chrVIII                           \+                                    168597    168614    TTGTGTCATATTTAGAC   0.799695233   chrVIII   \-   168793    168776    TATATATATATATACGT   0.820409776   196
  99    chrVIII                           \+                                    245788    245805    CTATTTTATGATTAGTT   0.939777326   chrVIII   \-   245940    245923    CAATTCCAAATTTAGGC   0.831524522   152
  100   chrVIII                           \-                                    392260    392243    TTTTTTCTTGAGTACTT   0.788764838   chrVIII   \+   392088    392105    ATAATTTACATTAATAT   0.821200767   172
  101   chrVIII                           \-                                    447794    447777    TATGTTTATGTTTTGTG   0.947093715   chrVIII   \+   447598    447615    TTGCTTAATATTTTGCA   0.846461752   196
  102   chrVIII                           \-                                    501949    501932    CGTTTATACATTTTGTT   0.896794884   chrVIII   \+   501752    501769    ATATTTTACGGTTCTTT   0.824337524   197
  103   chrVIII                           \+                                    556140    556157    AATTTTTACGTTTAGGT   0.969507836   chrVIII   \-   556301    556284    CATTTTAATATCTATAT   0.829435873   161
  104   chrIX                             \-                                    105966    105949    ATTATTCATGTTTTCTT   0.92780469    chrIX     \+   105812    105829    AATAATAATAATAATGG   0.754881026   154
  105   chrIX                             \-                                    136290    136273    GCAGTTTATGTTTTGTT   0.905839044   chrIX     \+   136160    136177    GATATCTATATTTTATA   0.840946348   130
  106   chrIX                             \+                                    175173    175190    ATGTTTTATGTTTTGTC   0.936874196   chrIX     \-   175339    175322    CAATTTCAAATTTAAAA   0.82970169    166
  107   chrIX                             \+                                    214735    214752    TTAATTTATGTTTTGTA   0.95530712    chrIX     \-   214909    214892    TGTTTTTATATATTCGT   0.841209426   174
  108   chrIX                             \-                                    245882    245865    TTTTTTAATGTTTTGTC   0.962520612   chrIX     \+   245773    245790    CCTTAAAAAGGTCTCAC   0.67119524    109
  109   chrIX                             \-                                    247754    247737    TTTTTTAATGTTTTGTC   0.962520612   chrIX     \+   247631    247648    TACATTTCTCTTTTTTT   0.823299168   123
  110   chrIX                             \-                                    342031    342014    TTTTTTAATGTTTAGCT   0.961127508   chrIX     \+   341853    341870    TAAGGTCTTGTTTGTTT   0.760099392   178
  111   chrIX                             \+                                    357225    357242    AATTTTTATATTTTGTT   0.983369656   chrIX     \-   357356    357339    TATTTATAGATTTTTCT   0.83281607    131
  112   chrIX                             \-                                    412003    411986    AATTTTAATGTTTTGTC   0.954569521   chrIX     \+   411895    411912    AAGGTATAAATGTAGTT   0.778441725   108
  113   chrX                              \-                                    7731      7714      TATTTTTATGTTTAGGT   0.992509265   chrX      \+   7570      7587      CATTTTAATATCTATAT   0.829435873   161
  114   chrX                              \-                                    67714     67697     CTTTTTTATTTTTTTTT   0.944897067   chrX      \+   67593     67610     AAAATTAATAAATTTCC   0.769826733   121
  115   chrX                              \+                                    99498     99515     TTTTTTAATTTTTTTTT   0.947088854   chrX      \-   99625     99608     TTTATTTATGTTTTGTT   0.988690479   127
  116   chrX                              \+                                    298616    298633    TGACTCTAACTCCAGTT   0.666661983   chrX      \-   298725    298708    CTAATAAAACTTTTTCC   0.801772328   109
  117   chrX                              \+                                    337049    337066    CTTAAATAAGGTGAAGA   0.678459288   chrX      \-   337193    337176    CTCTTGCTTGTTTAGTT   0.819488866   144
  118   chrX                              \+                                    374633    374650    AATTACTACAATTTTCG   0.788091986   chrX      \-   374774    374757    GAAATTTACATTTATTT   0.914653679   141
  119   chrX                              \-                                    375586    375569    TTAGTGCAAAATATGAG   0.674815863   chrX      \+   375403    375420    TTCTTTAAACTTTTTGA   0.856145267   183
  120   chrX                              \-                                    417088    417071    TTGATGCACTATCATGA   0.704755133   chrX      \+   416918    416935    GATTTCTATGTTCTCGA   0.808544598   170
  121   chrX                              \+                                    540294    540311    GGGTAAAATGCGCTGTA   0.572247037   chrX      \-   540461    540444    AAAAATTACTTCCAGTT   0.755451504   167
  122   chrX                              \-                                    612772    612755    CACCAACAAATTGACAG   0.600434727   chrX      \+   612662    612679    GGATTTCATAATTGTGG   0.785437954   110
  123   chrX                              \-                                    654253    654236    TAAAGTTAACGTAACCA   0.631991513   chrX      \+   654127    654144    TCAAAACTTGATTTGTT   0.783019587   126
  124   chrX                              \+                                    683708    683725    CAGATAAAACAGCATAT   0.624200951   chrX      \-   683904    683887    GTATTGTACATTTACCT   0.826577659   196
  125   chrX                              \+                                    711652    711669    ATTTCTAATGCCTTGTG   0.672178619   chrX      \-   711852    711835    TTTGTTCACTGTTAGTT   0.872596683   200
  126   chrX                              \+                                    729810    729827    TAGTTGAATAATTCGTA   0.742850129   chrX      \-   729989    729972    CGATTAAGCGTTTTGCC   0.743397787   179
  127   chrX                              \-                                    736901    736884    CAATTGGAAAATTAGTG   0.76415065    chrX      \+   736789    736806    TGTTTGAGTGTTCAGGT   0.744514544   112
  128   chrX                              \+                                    744625    744642    TAATTAGCACTTCTCCC   0.637153506   chrX      \-   744819    744802    GTAATATAACTGTACTC   0.72903611    194
  129   chrXI                             \-                                    55866     55849     TTCATTAATGTTTAGTT   0.937267458   chrXI     \+   55685     55702     ATTTTTCATCTTTATTA   0.906973964   181
  130   chrXI                             \+                                    98384     98401     TTTTTTTATGTTTAGTG   0.969509169   chrXI     \-   98530     98513     GTACTTTATTTTTGGTT   0.851436401   146
  131   chrXI                             \-                                    153120    153103    AATTTTTACAATTTGTC   0.919552201   chrXI     \+   152995    153012    TAGTTATAAGATTATCT   0.841554901   125
  132   chrXI                             \-                                    196216    196199    TTTTTTCATTTTTTGTT   0.951572253   chrXI     \+   196020    196037    TTTGCTCATTTTTAAGT   0.795946302   196
  133   chrXI                             \-                                    213317    213300    AGAGTTTGTCATTACCA   0.719440701   chrXI     \+   213207    213224    ATTAATAATCTGTATTT   0.803703635   110
  134   chrXI                             \-                                    329497    329480    GGTACTGAAATTTCGGT   0.675926258   chrXI     \+   329388    329405    AAAATTCTTGATGTGTT   0.785345702   109
  135   chrXI                             \+                                    388665    388682    GGTGTTTAAGGGTAAAT   0.710373823   chrXI     \-   388778    388761    TTCGTTTTTAGTTAGTA   0.833546833   113
  136   chrXI                             \+                                    416880    416897    CGCGAGATCCATAGGCT   0.528888624   chrXI     \-   416990    416973    TATATTCTTGATTGGAT   0.835644767   110
  137   chrXI                             \-                                    447845    447828    CACATACATATTTTAAC   0.785193796   chrXI     \+   447678    447695    GTAATAAATATTCTCAT   0.786845724   167
  138   chrXI                             \+                                    516676    516693    ACTTGTTATGGTTATGT   0.80432569    chrXI     \-   516825    516808    CATAATTGCCTTTTCTT   0.777169896   149
  139   chrXI                             \+                                    581535    581552    ACTATGTATCTTGCAGT   0.639967512   chrXI     \-   581699    581682    TATTTTTTTAATTATGC   0.885914166   164
  140   chrXI                             \-                                    612054    612037    TTTGGATTCATCTAACG   0.610536381   chrXI     \+   611861    611878    GAGAATGACGATTCCGT   0.681607383   193
  141   chrXI                             \+                                    642416    642433    GGATGCGACATTTAACT   0.658787349   chrXI     \-   642546    642529    CGCTTATATGTTGGTAT   0.720382898   130
  142   chrXII                            \+                                    91467     91484     CATTTTAACGTTTAGTT   0.947368024   chrXII    \-   91595     91578     TCCTTTAAACTTTAGTT   0.864360818   128
  143   chrXII                            \+                                    156701    156718    TGATTTTACTTTTTGGA   0.897074392   chrXII    \-   156822    156805    TAAGATTACGTTTTTAA   0.861864859   121
  144   chrXII                            \+                                    231249    231266    TTTGTTTATATTTTTGT   0.950585996   chrXII    \-   231358    231341    GTTGTTTAGTTTTATTT   0.830642974   109
  145   chrXII                            \-                                    289420    289403    AAAATTAATGTTTTGCT   0.929806448   chrXII    \+   289325    289342    TATATCCTTCTTTATAT   0.811743224   95
  146   chrXII                            \-                                    373327    373310    TTTTTTTATATTTTCTC   0.944189014   chrXII    \+   373227    373244    TTCGATAAAGGTTTGTC   0.807458273   100
  147   chrXII                            \-                                    412852    412835    ATGTTTTTTGTTTTGTT   0.918453308   chrXII    \+   412678    412695    GTTTTGTACCTTTAGCT   0.848513235   174
  148   chrXII                            \-                                    450659    450642    TTTTTTTATATCTTGCT   0.878438397   chrXII    \+   450505    450522    CGTTTTTATGTTTATTC   0.924039943   154
  149   chrXII                            \-                                    459090    459073    ATTGTTTATGTTTTGTG   0.940327272   chrXII    \+   458995    459012    CTATTCTATGTTTTCTT   0.886167882   95
  150   chrXII                            \-                                    513083    513066    TTTATTTATGTTTTTGT   0.968709027   chrXII    \+   512958    512975    ATTATAAACATTTTATA   0.845822907   125
  151   chrXII                            \-                                    603109    603092    TTTTTTAATGTTTATGT   0.962915946   chrXII    \+   602997    603014    GTTTTTATCAGTTTCAT   0.801484796   112
  152   chrXII                            \+                                    659892    659909    GCTTTTTATGTTTATTT   0.92663958    chrXII    \-   660003    659986    AGTATTCATGTTTTACT   0.871065837   111
  153   chrXII                            \-                                    745115    745098    TATCTTTATGTTTTGTT   0.949064504   chrXII    \+   745006    745023    TCGTTCAAACTTTTGTC   0.79040136    109
  154   chrXII                            \-                                    794207    794190    AAAGTTTAAGTTTAGTT   0.935806549   chrXII    \+   794096    794113    TTTGATCATAATTATTT   0.872143422   111
  155   chrXII                            \-                                    888740    888723    GTTTTTTATGTTTAGAT   0.952111375   chrXII    \+   888618    888635    AATTTTTATAATTAATG   0.88656275    122
  156   chrXII                            \+                                    1007232   1007249   ATGTTTCATATTTTTAT   0.888016553   chrXII    \-   1007338   1007321   AAAATTTATAATTTAGT   0.886785202   106
  157   chrXII                            \+                                    1013789   1013806   TTTTTTTATGTTTTCTC   0.951798435   chrXII    \-   1013882   1013865   AAACAGTACGTATTTTT   0.715569985   93
  158   chrXII                            \-                                    1024156   1024139   CTTAATGATGTTTAGTT   0.887516109   chrXII    \+   1024017   1024034   CTAGTTTTTAATTATAT   0.838833831   139
  159   chrXIII                           \+                                    31766     31783     GTAGTTTATTATTAGTT   0.89054401    chrXIII   \-   31876     31859     CATTAAAATAATTATAT   0.824526619   110
  160   chrXIII                           \-                                    94390     94373     ATTAATTATATTTAGAT   0.921181496   chrXIII   \+   94266     94283     ATGTTAAATATTTTATT   0.857637919   124
  161   chrXIII                           \+                                    137321    137338    AATATTTATGTTTTGTT   0.980739388   chrXIII   \-   137437    137420    TTGTTATTTATTTTTGA   0.841585149   116
  162   chrXIII                           \-                                    184017    184000    GTTATATATGGTTAGTT   0.884678994   chrXIII   \+   183864    183881    ACATTAAATATTTTTGG   0.834854862   153
  163   chrXIII                           \+                                    263126    263143    ATTTTTTATATTTTGTG   0.953471148   chrXIII   \-   263313    263296    TATGTATATATTTATCT   0.900878883   187
  164   chrXIII                           \+                                    286846    286863    ATTTTTCTTATTTAGTT   0.921601724   chrXIII   \-   286946    286929    AGGATTTATGTTTTTTT   0.908582747   100
  165   chrXIII                           \+                                    371020    371037    AATTTTATTGTTTAGTT   0.937218464   chrXIII   \-   371128    371111    CACTTATATTTTTTTAT   0.851831461   108
  166   chrXIII                           \+                                    468237    468254    TTTTTTTATTTTTTGTT   0.977274497   chrXIII   \-   468357    468340    ATCATTTTTAATTAGTA   0.851483278   120
  167   chrXIII                           \-                                    535770    535753    TTAATTTATATTTAGTT   0.970090441   chrXIII   \+   535662    535679    AGTTGTTTTGTTTTTTT   0.82595884    108
  168   chrXIII                           \+                                    611318    611335    ATTGTTTATGTTTATGT   0.951906482   chrXIII   \-   611459    611442    ATTTGGCATCATTGTAT   0.685281331   141
  169   chrXIII                           \+                                    634521    634538    TATTTTTACTATTTGTA   0.910848762   chrXIII   \-   634639    634622    CAATTTTATGGTCATTT   0.857274617   118
  170   chrXIII                           \+                                    649362    649379    TTATTTCATATTTTGTT   0.953558055   chrXIII   \-   649549    649532    CTTACTAACAATTTCTC   0.76251583    187
  171   chrXIII                           \-                                    758417    758400    AAATTTTATGTTTTTTT   0.965835588   chrXIII   \+   758312    758329    ACTTAGCGCGGTTTTTT   0.674331603   105
  172   chrXIII                           \+                                    772677    772694    TTTTTTTACTATTACTT   0.90600905    chrXIII   \-   772820    772803    AATTTATACAACTATAT   0.778650456   143
  173   chrXIII                           \+                                    805162    805179    TATTTTTGTATTTAGTC   0.881724676   chrXIII   \-   805312    805295    TTTTTTTACCTTTTTCC   0.903568549   150
  174   chrXIII                           \+                                    815391    815408    AAATTCTATGTTTTGTT   0.925335958   chrXIII   \-   815493    815476    ATTTTTTTTTTTTTGGA   0.903966564   102
  175   chrXIII                           \-                                    897976    897959    TTTTTTTATGTTTGGTT   0.960544596   chrXIII   \+   897881    897898    TTATTTTATCATTTTCT   0.89758988    95
  176   chrXIV                            \-                                    28654     28637     TTTTTTTATTTTTAGGT   0.971445917   chrXIV    \+   28486     28503     AAGTTAGATAATTAGCG   0.781498458   168
  177   chrXIV                            \+                                    61695     61712     GTTTTTAATGTTTTGTA   0.934385921   chrXIV    \-   61857     61840     TTTATTTAAATTTTGCC   0.916575598   162
  178   chrXIV                            \-                                    89756     89739     TATTTTTAAGTTTTGTT   0.974909231   chrXIV    \+   89644     89661     CTACTTATAGTTTTTCT   0.805190002   112
  179   chrXIV                            \-                                    169748    169731    TAATTTAACGTTTTGTT   0.953532134   chrXIV    \+   169589    169606    TTTATATATATGTATGT   0.835743836   159
  180   chrXIV                            \-                                    196225    196208    TTTTTTAACTTTTAGCC   0.904522219   chrXIV    \+   196096    196113    TTCGTAAAAATTTTTGC   0.820044435   129
  181   chrXIV                            \-                                    250464    250447    AATTTTTACGGTTTTTT   0.918603933   chrXIV    \+   250330    250347    GATAAACATATTCTTGT   0.787486687   134
  182   chrXIV                            \-                                    280066    280049    ATTATTTATGTTTTTCT   0.94647878    chrXIV    \+   279948    279965    ATAATAATTAATTAGTT   0.843720251   118
  183   chrXIV                            \+                                    322003    322020    TTTGTTTACGTTTAGGC   0.937398674   chrXIV    \-   322198    322181    GTTATAAATATTTATAA   0.847440569   195
  184   chrXIV                            \-                                    412441    412424    TTTTTTTATATTTCTGC   0.869234054   chrXIV    \+   412299    412316    CAACTTCTACATTACAT   0.72789922    142
  185   chrXIV                            \-                                    449536    449519    CATATTTACATTTAGCC   0.905544669   chrXIV    \+   449372    449389    TAAATACACTGTTATTT   0.822061337   164
  186   chrXIV                            \+                                    499040    499057    TTTCTTTATGTTTAGCT   0.928956769   chrXIV    \-   499150    499133    TATCTCTTCTTTTTGTT   0.820455656   110
  187   chrXIV                            \-                                    546149    546132    TATTTTTACGTTTTGGC   0.956489817   chrXIV    \+   545981    545998    AACATTAGTATTTAATT   0.792422254   168
  188   chrXIV                            \-                                    561330    561313    TTTGTTCACATTTAGTT   0.930292374   chrXIV    \+   561216    561233    TTGATTTACATTCAAAC   0.797477323   114
  189   chrXIV                            \+                                    609536    609553    TTTTTTTATGTTTATTT   0.986916959   chrXIV    \-   609674    609657    TATTTATGTCTTTACTT   0.819944062   138
  190   chrXIV                            \-                                    635833    635816    TTTTTTTAATTTTAGTT   0.954915715   chrXIV    \+   635716    635733    TGTTTTTTTTTTTTGCA   0.87217818    117
  191   chrXIV                            \-                                    691680    691663    GTAATTAACATTTTGTT   0.910156612   chrXIV    \+   691559    691576    GATATTTCCCTTTTGGA   0.801789741   121
  192   chrXV                             \+                                    35714     35731     TATATTTATATTTAGAG   0.929297843   chrXV     \-   35855     35838     CATATTTATGTTTCATT   0.847487414   141
  193   chrXV                             \+                                    72688     72705     TTTTTTTACTTTTAGTT   0.962701666   chrXV     \-   72794     72777     TTTTATCACGTTTAGCA   0.883721557   106
  194   chrXV                             \-                                    85366     85349     TATACCTATATTTATGT   0.817468435   chrXV     \+   85268     85285     GCTTTTAATTTTTATTT   0.887881307   98
  195   chrXV                             \+                                    113895    113912    ATTGTTTATATTTTTGT   0.943227229   chrXV     \-   114058    114041    TAATATCATGTTTTATA   0.868893438   163
  196   chrXV                             \+                                    167003    167020    TTTATTTATGTTTTCGT   0.95396729    chrXV     \-   167143    167126    TTTAAAACTGTTTACGT   0.78001402    140
  197   chrXV                             \-                                    277732    277715    GTTGTTTATCTTTTGTT   0.926499065   chrXV     \+   277562    277579    TTATAAAAAATTTATTT   0.859561998   170
  198   chrXV                             \-                                    337483    337466    TCTTTTTACCTTTTGTC   0.904262836   chrXV     \+   337385    337402    TATTTTAGTATTTATTT   0.870845988   98
  199   chrXV                             \+                                    436790    436807    TATATTTATTTTTATTC   0.935122318   chrXV     \-   436888    436871    TTCTTTTTTCATTTATT   0.832867098   98
  200   chrXV                             \-                                    490060    490043    GTTGTTTTTCTTTTCTT   0.860946443   chrXV     \+   489890    489907    TAAGTTTATATTTTGGT   0.951016266   170
  201   chrXV                             \-                                    566597    566580    AAATTTTACCTTTTGAT   0.915947006   chrXV     \+   566499    566516    AATATTTAATATCTCTT   0.824916747   98
  202   chrXV                             \+                                    656701    656718    CTATTTAATGATTAGTA   0.901351813   chrXV     \-   656901    656884    GTTGATTTCTTTTTCTT   0.817366446   200
  203   chrXV                             \+                                    729795    729812    TATTTTTATATTTTGGC   0.964523057   chrXV     \-   729894    729877    TTCTTTCATTTTTGTAC   0.823636542   99
  204   chrXV                             \+                                    766689    766706    GTATTTTACGTTTTTTC   0.912718329   chrXV     \-   766791    766774    TATTTTAAATTTCTGTA   0.860782306   102
  205   chrXV                             \+                                    783386    783403    TATTTTTAACTTTTGGT   0.942451749   chrXV     \-   783582    783565    TCTTTTTATCTCTTCAA   0.777182413   196
  206   chrXV                             \-                                    874370    874353    CATTTTAATATTTGTTA   0.881539907   chrXV     \+   874192    874209    AAGTTTTCCGTTTAGCA   0.807156571   178
  207   chrXV                             \+                                    908307    908324    CTAAACTTTGTTTATGT   0.815272772   chrXV     \-   908439    908422    GGTTTTTTTTTTTAAGT   0.8448056     132
  208   chrXV                             \+                                    981507    981524    TTTTTTTATTTATATTT   0.874148828   chrXV     \-   981603    981586    TTTTTTCATGATTTTGT   0.924378634   96
  209   chrXV                             \+                                    1053687   1053704   TAATTAATTGTTTTGTT   0.896133812   chrXV     \-   1053797   1053780   CGATTAAATGTTTTTAT   0.856030986   110
  210   chrXVI                            \-                                    43150     43133     TTTGTTTATATTTTTGA   0.929263085   chrXVI    \+   42958     42975     TTCTTTTACCTTTAATA   0.863567037   192
  211   chrXVI                            \+                                    73104     73121     GTTTTTTTTGTTTTTTC   0.902693595   chrXVI    \-   73301     73284     TATATTTATAATTATAA   0.896514883   197
  212   chrXVI                            \+                                    116593    116610    TATTTTTATGTTTTGTT   0.998337845   chrXVI    \-   116770    116753    TAAAATTAAGTTTTGCG   0.868507637   177
  213   chrXVI                            \+                                    289531    289548    ATAATTAATGTTTACTT   0.925413716   chrXVI    \-   289675    289658    AAAGTTAATTTTTATAT   0.885623957   144
  214   chrXVI                            \+                                    384591    384608    TATTCTAAAATTTATGT   0.840759582   chrXVI    \-   384718    384701    TTTAAATATATTTAAGT   0.869580534   127
  215   chrXVI                            \+                                    418177    418194    TTCTTTCTTATTTACAA   0.82265266    chrXVI    \-   418289    418272    TATTATTTTGTTTTCTT   0.900944489   112
  216   chrXVI                            \-                                    456763    456746    TTTTATTATTTTTTGTT   0.945433762   chrXVI    \+   456626    456643    CTTATTCACAATTTCAA   0.820656345   137
  217   chrXVI                            \+                                    511708    511725    TATTTTTATGTTTTTTG   0.954763972   chrXVI    \-   511820    511803    GTGGTTATCATTTATTT   0.826572147   112
  218   chrXVI                            \+                                    563881    563898    AGTCTTTTATATTTAGT   0.760925944   chrXVI    \-   563991    563974    TCTAAATATATTCATCT   0.791939697   110
  219   chrXVI                            \+                                    565119    565136    TGTTTTTAATTTTTAGT   0.884153732   chrXVI    \-   565272    565255    TTTTTGGTTCTTTTGTT   0.822137769   153
  220   chrXVI                            \+                                    633925    633942    CGTTTTTATAGTTTAGT   0.858684766   chrXVI    \-   634064    634047    TTGTTTTATATTTAACA   0.875389458   139
  221   chrXVI                            \+                                    684409    684426    TTTTTTTTACTTTTTGT   0.892233188   chrXVI    \-   684534    684517    CATATGTTTGTTTAGCT   0.847979457   125
  222   chrXVI                            \-                                    695624    695607    TTTTTTTTTAATTTTCT   0.889872135   chrXVI    \+   695470    695487    AATTTTTATATTTGGTT   0.944984083   154
  223   chrXVI                            \+                                    749121    749138    AATTTTTAAGTTTAGTA   0.947297384   chrXVI    \-   749222    749205    ATAATTTACATTTTATT   0.907501113   101
  224   chrXVI                            \-                                    777098    777081    TTTATTTATATTTTGGC   0.954875691   chrXVI    \+   776923    776940    AATGTGTTAGTTTTTCT   0.811819984   175
  225   chrXVI                            \-                                    819345    819328    AATTTTTATATTTATTC   0.952049491   chrXVI    \+   819204    819221    TATATTATCATATAGTT   0.819972999   141
  226   chrXVI                            \-                                    842856    842839    TTTATTTAGATTTAGTT   0.894404608   chrXVI    \+   842714    842731    AATTTTAATCTTTAGTA   0.928064324   142
  227   chrXVI                            \+                                    880904    880921    CTCATATATATTTTATG   0.822074378   chrXVI    \-   881035    881018    TAACTCTAACTTTTTTA   0.800027746   131
  228   chrXVI                            \-                                    933170    933153    CTTATTTACGTTTAGCT   0.93305337    chrXVI    \+   933047    933064    ATTCAAAATATTTTGGA   0.822210839   123
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Pervasive transcription fine-tunes replication origin activity\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by Bruce Stillman as Reviewing Editor and Kevin Struhl as the Senior Editor. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

This paper aims to define how transcription influences replication origin function in budding yeast. It is known that transcription through origin sequences can influence DNA replication, but it is unclear how many origins are affected. mRNA abundance, measured at steady state, is a poor indication of ongoing transcription so Candelli et al. use a newer method to map nascent RNA and RNA polymerase occupancy across the genome. Their most prominent conclusions are: (1) that replication origins function as strong transcription terminators; (2) termination sites are correlated with ACS locations; (3) most origins utilize two ACS sequences -- by implication two sites for ORC loading; (4) ORC, Cdc6 or the entire pre-RC mediates transcription termination; (5) transcription through some replication origins influences origin activity.

Taken together this report provides a solid advance for our understanding of how transcription may influence origin activity, or how assembly of proteins at origins of DNA replication affect transcription. The major finding, which is convincingly supported by the data, is the demonstration that proteins assembled in an ORC- and Cdc6-dependent manner can inhibit transcriptional elongation. This result is likely to be of broad interest. The second important finding is that the level of transcription across origins may influence origin activity. Beyond these findings the paper does not elaborate a more comprehensive understanding of how transcription may influence origin function. The role of the second ACS/ORC binding site is not particularly well supported; how and why some origins are more sensitive to transcription is also not defined.

The paper is of sufficient interest and the authors are requested to respond to specific issues, some relating to individual conclusions. The following are specific issues that the reviewers have raised about the manuscript that need to be addressed before publication.

Essential revisions:

1\) It is clear that transcription can terminate in the vicinity of the primary ACS, however the data showing termination near the secondary ACS is unconvincing. The data in Figure 1D, E are noisy (see point 2 below) and the small peak near the secondary ACS could be an artifact from a single over-represented site.Further investigation of the second ACS site in the paper is also not particularly convincing. Thus, the conclusions about these data supporting the model that multiple ORC proteins assemble the pre-RC are not warranted.

2\) Related to point 1, the authors use the technique of Schaughency et al., 2014 for measuring RNA reads at genomic loci. The data in Schaughency et al., 2014 show mean reads of 30-60 (e.g., near Poly A sites), but the data in Figure 1 A show mean number of RNAPII reads of 2-7 near origin sequences. How significant are these reads? Is there anywhere in the genome that does not have reads of at least 2-7 (i.e., lacks RNAPII)? The low reads could be experimental background and the dip could be because a protein (ORC-Cdc6) is bound at the origin. Again, what are the mean reads near poly(A)+ sites analyzed in Figure 1B. Only a summary of the location of these reads is shown. Showing the mean Poly(A)+ reads over the origin in addition to the summary analysis would be more convincing. Figure 1D: Again, the number of reads is very low and this could be due to random noise. What is convincing about the peaks, particularly at secondary ACS sites?

3\) The data in Figure 2 is interpreted to show significant roadblock of RNA polymerase II at ACS sites. However, given that the mapped signal fluctuates significantly across the regions shown, it is unclear how the authors can conclude that one specific site is a \"roadblock\" whereas another nearby site isn\'t? Specifically, Figure 2A and subsection "RNAPII pausing and transcription termination occur at ARS borders". The light green track in Figure 2A show that in the mutant, many peaks of RNAPII pausing are observed, but the authors only point to the ACS. Why? What about all the other peaks in the track? Same for Figure 2B, Figure 2C and Figure 2D and yet the authors point out that ACSs are occupied by ORC. But ORC or the pre-RC is most likely not at the other pauses.

4\) The Abstract states, \" We provide evidence that quasi-symmetrical binding of the ORC complex to ARS borders is responsible for pausing/termination.\" This is too strong a statement since they have not shown that ORC does this. Indeed, it is shown that Cdc6 mutants also compromise termination. It could be that loaded pre-RC or the Mcm2-7 double hexamers are the terminator, not ORC. Please clarify the abstract, otherwise it will become accepted that ORC causes termination

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

Thank you for resubmitting your work entitled \"Pervasive Transcription Fine-tunes Replication Origin Activity\" for further consideration at *eLife*. Your revised article has been favorably evaluated by Kevin Struhl (Senior Editor) and a Reviewing Editor.

The revised paper has been improved and the authors have addressed the questions raised by the reviewers. As such it is now appropriate for publication in *eLife*, with some modifications or a brief response to issues raised below. The paper does show that proteins assembled at ARS origins can contribute to termination of transcription through the origin. The problem remains in the interpretation of the results and here the authors even propose contradictory ideas. In re-reading the paper, there are some miss-statements or contradictions that could be corrected.

These are:

Introduction, the authors should reference that Steve Bell\'s laboratory, who performed the cited single molecule experiments, but has published subsequent research consistent with the two ORC-Cdc6 model. Thus, the paragraph about a controversy should be toned down and their reference cited in the Introduction \[Warner et al. (2017)\].

Introduction. The paragraph starts of by stating that \"Studies have proposed that transcription might activate replication origins\" and then in the second sentence Marahrens and Stillman, 1992 is cited as evidence. Marahrens and Stillman, 1992 did not propose that transcriptional activators activate replication by via transcription, but by activators likely modulating chromatin structure. Thus, this paper does not support the hypothesis by the authors. Even Stagljar et al., 1999 did not show that transcription activates an origin. These papers are not \"in apparent contrast with the demonstration that strong transcription through ARSs is detrimental for their function\" (Introduction). While it is true that transcription is detrimental for replication initiation, accurate citing of references is needed.

Subsection "Topological organization of replication origin factors detected by transcriptional footprinting" and later in subsection "Functional implications for pervasive transcription at ARS". The authors argue that transcription may \"play an important role\" in the initiation of DNA replication by pushing the first loaded Mcm2-7 hexamer away from the ORC binding site. This is clearly not the case since initiation of DNA replication in vitro is very efficient and does not require transcription, even on chromatin templates (Kurat et al., 2017). It seems the authors are stating on one case that ARSs and their binding proteins terminate transcription and yet then state that transcription may play an important role in replication initiation. This, based on the data presented, does not seem likely (at least it has not been demonstrated). Indeed, subsection "Functional implications for pervasive transcription at ARS", the authors state \" We propose that transcription though origins might induce similar changes that are susceptible to outcompete binding of ORC and/or pre-RC formation.\" They cannot have it both ways.

10.7554/eLife.40802.025

Author response

> Essential revisions:
>
> 1\) It is clear that transcription can terminate in the vicinity of the primary ACS, however the data showing termination near the secondary ACS is unconvincing. The data in Figure 1D, E are noisy (see point 2 below) and the small peak near the secondary ACS could be an artifact from a single over-represented site. Further investigation of the second ACS site in the paper is also not particularly convincing. Thus, the conclusions about these data supporting the model that multiple ORC proteins assemble the pre-RC are not warranted.
>
> 2\) Related to point 1, the authors use the technique of Schaughency et al., 2014 for measuring RNA reads at genomic loci. The data in Schaughency et al., 2014 show mean reads of 30-60 (e.g., near Poly A sites), but the data in Figure 1 A show mean number of RNAPII reads of 2-7 near origin sequences. How significant are these reads? Is there anywhere in the genome that does not have reads of at least 2-7 (i.e., lacks RNAPII)? The low reads could be experimental background and the dip could be because a protein (ORC-Cdc6) is bound at the origin. Again, what are the mean reads near poly(A)+ sites analyzed in Figure 1B. Only a summary of the location of these reads is shown. Showing the mean Poly(A)+ reads over the origin in addition to the summary analysis would be more convincing. Figure 1D: Again, the number of reads is very low and this could be due to random noise. What is convincing about the peaks, particularly at secondary ACS sites?

Essential revisions \#1 and \#2 are very much related and will be answered together below. For matching questions and answers we added to each question or group of related questions a letter (A, B and C) that refers to the answer.

A\) On the significance of RNAPII pausing at the primary ACSs

The first concern we will discuss is the significance of the distribution of RNAPII around origins at the primary sites. As stated in the manuscript, the main aim of these analyses was to assess the impact of the low levels of pervasive transcription around origins, transcription that is generally non-annotated and often due to readthrough at canonical terminators. It is therefore expected that the average level of reads around origins be lower than the genome average of 30-60 reads, since we are sampling the lowest percentile of the distribution. Importantly, however, we did not profile the *mean* levels of reads but the *median*, which was done precisely in order to undermine the contribution of highly represented sites. With a less stringent analysis, i.e. when plotting the mean values ([Author response image 1](#respfig1){ref-type="fig"}), the levels of the RNAPII reads in the region of the roadblock (around 15) are very comparable with the genome average as cited by the referee (30-60) and the drop in the signal clearly visible.

![RNAPII ParCLIP reads (mean values) are profiled around origins aligned on the first nucleotide of the primary ACS.](elife-40802-resp-fig1){#respfig1}

However, we believe that presenting these data could be misleading, as at least a fraction of the signal at the roadblock could be due to a very limited number of sites with high values. Indeed, some peaks are only visible using the mean (see for instance the peak at +200) and clearly due to outliers that do not represent the overall population (in this case probably a site of initiation after the origin).

Use of the median is more stringent and generally more appropriate for representing distribution that deviate from normality.

We considered that good evidence for the existence of a significant signal at the roadblock would be loss of that signal immediately after the ACS. Therefore, we compared the reads levels in the 100nt before and after the ACS for every region (Figure 1---figure supplement 2A). The distributions of these values for the 100 origins with the highest levels of surrounding transcription are now shown in Figure 1---figure supplement 2B under the form of Box Plots. It appears clearly that the median signal is higher before the ACS and drops immediately after, and that the loss of signal is highly significant according to both parametric and non-parametric tests. A strong statistical significance is observed even when all the origins are considered (data not shown).

This signal derives from the crosslinking of the nascent RNA to the polymerase, and the absence of signal (and nascent RNA) can only derive from the failure of RNAPII from actively transcribing that particular region. The drop in the RNAPII signal occurs thereforebecause of the presence of a protein complex bound at the ACS. This is not a technical artefact as the one that could be expected from ChIP datasets, in which the absence of crosslinking could be due to the steric hindrance due to another complex bound at the same location. Lastly, we would also like to stress that the poor signal around ACSs cannot be ascribed to the poor \"mappability\" of reads derived from such AT rich regions, because: i) similar AT-rich regions elsewhere in the genome have signals and ii) a signal at origins can be detected when incoming transcription is \"forced\" in transcription termination mutants (e.g. *rna15-2* or *NRD1::AID*).

B\) On the significance of RNAPII pausing at the secondary ACSs

We agree with the referees that we did not provide a strong experimental support for the existence of a second ORC complex bound to the secondary ACS. We did our best to tone down these claims and we only claim consistency with this hypothesis in the revised manuscript.

Concerning the analyses of transcription around the putative secondary ACSs, we did not intend to claim that secondary ACSs induce transcription termination and apologize if this was not sufficiently clear in the manuscript. In Results section and subsection "Topological organization of replication origin factors detected by transcriptional footprinting"of the original manuscript we had proposed that the best interpretation of the data shown in Figure 1D-E is that RNAPII pauses at the secondary ACS but that termination occurs later on, which is actually the basis of the asymmetry that we observed. We have added a few sentences to strengthen this notion in the revised version of the manuscript. We also added a probability profile of termination around secondary ACS (see below, Figure 1---figure supplement 2E) from which it is clear that statistically significant termination only occurs after the ACS.

Concerning the significance of the RNAPII occupancy peak upstream of the putative secondary ACSs, we plotted in Figure 1D the *median* number of reads and not the average. By definition, the peak in the median profile upstream of the secondary ACSs cannot be due to the contribution of only a single (or a few) overrepresented values as it depends on half of the values of the distribution. To further support the significance of RNAPII pausing upstream of the secondary ACSs, we compared the distributions of RNAPII levels before and after the aligned, putative secondary ACSs. Here again we found a very significant decrease in the signal (Figure 1---figure supplement 2C).

C\) On the significance of termination at primary ACSs

Finally, the referees request the metaprofile of the mean level of RNA 3'-ends around ACSs. We would like to stress that the question addressed in Figures 1B,1E, Figure 4A and 4B was whether termination occurred upstream of origins, using as a proxy the presence/absence of RNA 3' ends in the regions analyzed. Because the RNAs produced can have different stabilities, the average 3'-ends signal (as opposed by the 3'-ends count) is strongly influenced by the steady state level of the RNAs. Using this indicator for termination might introduce a major bias, as one or a few RNAs with high steady state levels would dominate the signal, which would be artefactual. This was particularly relevant at origins because many of the RNAs produced in these regions are poorly abundant, and because roadblocked transcription events tend to produce mainly non-coding and unstable RNAs (Colin et al., 2014).

Since it is the occurrence of termination events that we profile independently of the RNA steady state levels, profiling the average 3'-ends signal would therefore not be appropriate.

Nevertheless, to convince the referees that there is increased occurrence of termination events immediately preceding the average ACS, we calculated the statistical significance of the observed number of termination events at the ACS peak. To do so, we adopted the H0 hypothesis that termination occurs with equal frequency in the whole region of alignment (-500 to +500 from the ACS), and calculated a p-value for each position based on the frequency observed in the first 100nt window (position -500) and on the actual values observed at every position.

As shown in Figure 1---figure supplement 2D, the frequency of termination events is not significantly different in most of the region. However, a prominent peak of very low p-value is seen immediately *upstream* of the ACS, demonstrating that termination occurs with higher frequency in this region (p\<10^-20^). We also performed the same analysis around secondary ACSs (Figure 1---figure supplement 2E), from which it is clear that termination occurs with high significance only *after* the ACS.

We conclude from these analyses, which have been included in the revised version of the manuscript, that transcription termination occurs immediately upstream of the primary ACSs with high statistical significance.

> 3\) The data in Figure 2 is interpreted to show significant roadblock of RNA polymerase II at ACS sites. However, given that the mapped signal fluctuates significantly across the regions shown, it is unclear how the authors can conclude that one specific site is a \"roadblock\" whereas another nearby site isn\'t? Specifically, Figure 2A and subsection "RNAPII pausing and transcription termination occur at ARS borders". The light green track in Figure 2A show that in the mutant, many peaks of RNAPII pausing are observed, but the authors only point to the ACS. Why? What about all the other peaks in the track? Same for Figure 2B, Figure 2C and Figure 2D and yet the authors point out that ACSs are occupied by ORC. But ORC or the pre-RC is most likely not at the other pauses.

We thank the referees for giving us the opportunity to clarify this point. The snapshots in Figure 2 are only shown with the purpose of illustrating the behavior of RNAPII around specific origins. These snapshots alone do not demonstrate that the pausing that is observed is specifically due to the presence of an origin. Indeed, many additional sites of pausing are observed within genes and sometimes in the downstream region, at a distance from origins. What is telling us that ACS sequences induce pausing is the aggregate signal (Figure 1), in which other sites of pausing are averaged out while pausing immediately preceding the ACSs remains visible. This implies that pausing occurs at the *majority* of origins; otherwise it would not be detected by the *median*. Also, note that RNAPII pausing peaks at ACSs often appear after a region of low signal, which is consistent with an accumulation of polymerases fed by low levels of upstream readthrough transcription. To better highlight this point we have modified Figure 2 by adding an inset at panel 2A.

> 4\) The Abstract states \" We provide evidence that quasi-symmetrical binding of the ORC complex to ARS borders is responsible for pausing/termination.\" This is too strong a statement since they have not shown that ORC does this. Indeed, it is shown that Cdc6 mutants also compromise termination. It could be that loaded pre-RC or the Mcm2-7 double hexamers are the terminator, not ORC. Please clarify the abstract, otherwise it will become accepted that ORC causes termination.

We agree, we did not show that ORC alone is sufficient for termination, only that is necessary. We modified the abstract as requested.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

> The revised paper has been improved and the authors have addressed the questions raised by the reviewers. As such it is now appropriate for publication in eLife, with some modifications or a brief response to issues raised below. The paper does show that proteins assembled at ARS origins can contribute to termination of transcription through the origin. The problem remains in the interpretation of the results and here the authors even propose contradictory ideas. In re-reading the paper, there are some miss-statements or contradictions that could be corrected.

We thank the editors for re-evaluating favorably our revised manuscript. We briefly answer below to the last concerns.

> These are:
>
> Introduction, the authors should reference that Steve Bell\'s laboratory, who performed the cited single molecule experiments, but has published subsequent research consistent with the two ORC-Cdc6 model. Thus, the paragraph about a controversy should be toned down and their reference cited in the Introduction \[Warner et al. (2017)\].

This reference had been included in the original manuscript subsection "Topological organization of replication origin factors detected by transcriptional footprinting") to discuss the possible sliding of an intermediate during helicase loading. Results presented in Warner et al. are consistent with the quasi-symmetrical model, as the authors suggest, but do not prove that ORC binds to the B2 element when sliding is prevented. We therefore cited the work as \"see also\", together with the Coster et al. article. We also eliminated the notion of controversy, but we believe that the single molecule studies of the Bell and Greene laboratories should still be referenced.

> Introduction. The paragraph starts of by stating that \"Studies have proposed that transcription might activate replication origins\" and then in the second sentence Marahrens and Stillman, 1992 is cited as evidence. Marahrens and Stillman, 1992 did not propose that transcriptional activators activate replication by via transcription, but by activators likely modulating chromatin structure. Thus, this paper does not support the hypothesis by the authors. Even Stagljar et al., 1999 did not show that transcription activates an origin. These papers are not \"in apparent contrast with the demonstration that strong transcription through ARSs is detrimental for their function\" (Introduction). While it is true that transcription is detrimental for replication initiation, accurate citing of references is needed.

We had cited these papers for reporting that transcription activators binding is required for efficient origin firing (Introduction: \"The binding of general transcription factors such as Abf1 and Rap1, or even the tethering of transcription activation domains, TBP or Mediator components was shown to be required for efficient firing of a model ARS\"). Indeed, these studies do not show that transcription is induced at the studied origins, but they do not prove either that it is not. In the Stagljar et al. paper, this is actually suggested. This is why we considered this in apparent contradiction with the notion that strong transcription inactivates origins. We clarified this point and also deleted the first sentence that was associated to incorrect references. The reference to the Knott et al. study was associated to the references describing the importance of transcription factors at origins.

*Subsection "Topological organization of replication origin factors detected by transcriptional footprinting" and later in subsection "Functional implications for pervasive transcription at ARS". The authors argue that transcription may \"play an important role\" in the initiation of DNA replication by pushing the first loaded Mcm2-7 hexamer away from the ORC binding site. This is clearly not the case since initiation of DNA replication* in vitro *is very efficient and does not require transcription, even on chromatin templates (Kurat et al., 2017). It seems the authors are stating on one case that ARSs and their binding proteins terminate transcription and yet then state that transcription may play an important role in replication initiation. This, based on the data presented, does not seem likely (at least it has not been demonstrated). Indeed, subsection "Functional implications for pervasive transcription at ARS", the authors state \" We propose that transcription though origins might induce similar changes that are susceptible to outcompete binding of ORC and/or pre-RC formation.\" They cannot have it both ways.*

Our analyses are based on the average, negative effect of pervasive transcription on replication initiation. They do not exclude that in individual cases, pushing of the DH by transcription might also favor initiation of replication (even though this is not required in vitro). This is the reason of the apparent contradiction. Nevertheless, we agree that this is only a point of discussion and that we did not address here this possibility. Therefore, we eliminated the claim that transcription might favor firing by deleting this sentence.

Lastly, we also added a missing reference to the recent Soudet et al. paper.

[^1]: Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.

[^2]: These authors contributed equally to this work.
